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This bulletin provides a comprehensive overview of many different aspects of cannabis use in Ireland and Northern 
Ireland. It presents data relating to cannabis use on a lifetime (ever used), last year (recent use) and last month 
(current use) basis and compares these results with 2002/3 data. The bulletin also examines age of first use, 
regular use, types of cannabis used, method by which cannabis is used, how and where cannabis is obtained, 
reasons for stopping use, attitudes towards cannabis use, perceptions of risk and the profile of typical cannabis 
users. The survey was carried out by Ipsos MORI in Ireland and by the Central Survey Unit of the Northern Ireland 
Statistics and Research Agency in Northern Ireland according to standards set by the European Monitoring Centre for 
Drugs and Drug Addiction (EMCDDA).
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Ireland –  
Key Findings
n	Prevalence rates were highest among 
young adults. The lifetime prevalence 
rate for those aged 15-34 years was 
29%. The last year prevalence rate for 
young adults (10%) was at least three 
times higher than for older adults aged 
35-64 (3%) and last month prevalence 
rate was four times higher among young 
adults (4%) than older adults (1%).
n	Male respondents reported higher 
prevalence rates than females across all 
time periods. The lifetime prevalence rate 
for males was 27% compared to 17% 
for females.
n	The average age the respondents 
reported that they first used cannabis 
was 18 years for both males and 
females. The average age of first regular 
use was also 18 years.
n	Approximately one-in-four (24%) of 
current cannabis users used the drug on 
a daily or almost daily basis.
n	The majority of current users (93%) 
smoked cannabis in a joint.
n	Cannabis resin (also known as hash) was 
the most commonly used form of 
cannabis (60%); however, over one-third 
(38%) of current users reported smoking 
herbal cannabis (i.e. grass, weed, herb 
and skunk).
n	The majority of cannabis users were 
either given the drug by family/friends 
(44%) or shared the drug amongst 
friends (28%).
n	The majority of respondents (62%) 
considered it ‘very easy’ or ‘fairly easy’ to 
obtain cannabis within a 24-hour period.
n	Over one-quarter (26%) of respondents 
who said that they had ever taken 
cannabis reported taking the drug 
regularly. Of these the majority (66%) 
said they had stopped taking cannabis, 
10% had tried to stop but failed, whilst 
nearly one-in-four regular users (24%) 
had never tried to stop.
Northern Ireland – 
Key Findings
n	Prevalence rates were highest among 
young adults. The lifetime prevalence 
rate for those aged 15-34 years was 
35%. The last year prevalence rate for 
young adults (12%) was four times 
higher than for older adults aged 35-64 
(3%) and the last month prevalence rate 
for young adults (4%) was twice that of 
older adults (2%).
n	Male respondents reported higher 
prevalence rates than females across all 
time periods. The lifetime prevalence rate 
for males was 30% compared to 19% 
for females.
n	The average age respondents reported 
that they first used cannabis was 18 
years for males and 19 years for females. 
Among regular users, the average age of 
first use of cannabis was 16 years and 
the average age of first regular use was 
18 years.
n	Approximately one-in-six (16%) of 
current cannabis users reported using the 
drug on a daily or almost daily basis.
n	The majority of current users (85%) 
smoked cannabis in a joint.
n	Grass (43%) was the most commonly 
used form of cannabis; however one-
third of current users (33%) reported 
using cannabis resin.
n	More than one-third (35%) of recent 
cannabis users reported the drug was 
shared among friends, with another 30% 
being given the drug by family/friends.
n	Three-quarters of recent users (75%) 
considered it ‘very easy’ or ‘fairly easy’ to 
obtain cannabis within a 24-hour period.
n	Almost one-quarter (24%) of 
respondents who said that they had ever 
taken cannabis reported taking the drug 
regularly. Of these regular users, almost 
three-quarters (74%) said they had 
stopped taking cannabis, 13% had tried 
to stop but failed while another 13% had 
never tried to stop.
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Ireland
n	Lifetime use of cannabis increased among all adults aged  
15-64 from 17.4% in 2002/3 to 21.9% in 2006/7.
n	Increases in lifetime use of cannabis were found among 
males (from 22.4% to 27.0%), females (from 12.3% to 
16.6%), young adults aged 15-34 (from 24.0% to 28.6%) 
and older adults aged 35-64 (from 11.4% to 16.1%).
n	Last year use of cannabis increased among all adults aged 
15-64 from 4.5% in 2002/3 to 6.3% in 2006/7.
Northern Ireland
n	Lifetime use of cannabis increased among all adults aged  
15-64 from 16.8% in 2002/3 to 24.7% in 2006/7.
n	Increases in lifetime use of cannabis were also found among 
males (from 23.3% to 30.1%), females (from 10.5% to 
19.3%), young adults aged 15-34 years (from 25.1% to 
35.0%) and older adults aged 35-64 years (from 10.3%  
to 17.3%).
n	Last year use of cannabis increased among all adults aged 
15-64 from 5.4% in 2002/3 to 7.2% in 2006/7.
n	Increases in last year use were also seen among females 
(from 2.2% to 4.1%) and older adults aged 35-64 years 
(from 2.0% to 3.3%) between 2002/3 and 2006/7.
n	There were no significant increases in last month use of 
cannabis among any of the groups of respondents.
Comparisons in Prevalence Rates between 2002/ and 2006/7
All findings reported are statistically significant at least at the 5% level. Some of the findings presented here have previously been 
published in Bulletin 1.
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NWRDTF
L 18.9  10.7
LY 6.8  3.9
LM 0.7  0.0
MWRDTF
L 24.6 16.5
LY 9.2 5.5
LM 2.7 2.6
MRDTF
L 23.6 14.6
LY  8.5 5.1
LM 2.4 1.3
WRDTF
L 29.1* 14.6
LY 7.1* 1.5
LM 3.2 0.6
NERDTF
L 25.0 30.4
LY 7.8 10.6
LM 1.5 3.6
NRDTF
L 40.3 34.1
LY 18.9 12.6
LM 13.0 7.5
SERDTF
L 32.3 25.4
LY 9.8 11.2
LM 5.0 4.7
L = Lifetime
LY = Last Year
LM = Last Month
* Statistically significant
increase since 2002/2003
Figures in Black = 2006/7
Figures in Red = 2002/3
SRDTF
L 20.1 17.1
LY  8.6 7.9
LM 3.5 4.1
ECRDTF
L 38.1 33.4
LY 16.2 11.4
LM 5.5 7.5
SWRDTF
L 28.1 28.3
LY 8.8 10.0
LM 1.9 5.6
NHSSB
L 33.8*  22.8
LY 11.8  9.8
LM 2.5  6.1
SHSSB
L 25.6  23.9
LY 13.0  7.9
LM 7.8*  2.9
WHSSB
L 22.6  24.5
LY 8.3  9.4
LM 1.2  4.5
EHSSB
L 46.2*  27.4
LY 14.4  10.8
LM 3.6  6.6
Map 1: 
Cannabis Use: prevalence rates for young adults aged 15-34 years by Regional Drugs Task Force (RDTF) and Health and 
Social Services Board (HSSB) areas 2006/7
Purple boundary and shading highlights the RDTF areas.
HSSB areas are highlighted in pink shading.
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Introduction
The survey was commissioned by the National Advisory 
Committee on Drugs (NACD) in Ireland and the Public Health 
Information and Research Branch (PHIRB), formerly know as 
Drug and Alcohol Information and Research Unit (DAIRU), within 
the Department of Health, Social Services and Public Safety 
(DHSSPS) in Northern Ireland.
The main focus of the survey was to obtain prevalence rates for 
key illegal drugs, such as cannabis, ecstasy, cocaine and heroin, 
on a lifetime (ever used), last year (recent use), and last month 
(current use) basis. Similar prevalence questions were also asked 
of alcohol, tobacco, and other drugs (e.g. tranquillisers); 
attitudinal and demographic information was also sought from 
respondents.
Methodology
The questionnaire and methodology for this survey were based 
on best practice guidelines drawn up by the EMCDDA. The 
questionnaires were administered through face-to-face interviews 
with respondents aged between 15 and 64 normally resident in 
households in Ireland and Northern Ireland. Thus persons 
outside these age ranges, or who do not normally reside in 
private households, have not been included in the survey. This 
approach is commonly used throughout the EU and because of 
the exclusion of those living in institutions (for example, prisons, 
hostels) this type of prevalence survey is usually known as a 
general population survey.
Fieldwork for the survey was carried out between October 2006 
and May 2007 and the final achieved sample was 6,969 (4,967 
in Ireland and 2,002 in Northern Ireland). The response rate for 
the survey was 65% in Ireland and 62% in Northern Ireland. 
Area based sampling was applied in Ireland. The first stage 
involved stratifying by Health Board1/Regional Drugs Task Force 
(RDTF) area in Ireland. Within the Health Board/RDTF strata 
Electoral Divisions (EDs) were selected as areas. In Northern 
Ireland, the first stage involved stratifying by Health and Social 
Services Board (HSSB) areas and within the strata simple random 
sampling was used. The achieved sample was weighted by 
gender, age, RDTF area in Ireland and HSSB area in Northern 
Ireland, to maximise representativeness of the general population. 
The effects of stratification, clustering and weighting have been 
incorporated in the interval estimates (i.e. design effect adjusted). 
Details of the methodology have been summarised in a paper 
published on the websites of the NACD (http://www.nacd.ie/) 
and the DHSSPS (http://www.dhsspsni.gov.uk/) in 
1 Since January 2005 the Health Boards in Ireland have undergone 
restructuring and are merged under one authority – the Health Service 
Executive. However for the purpose of comparison with 2002/3 data, we 
have continued to weight the data by the former Health Board areas as 
these correspond with the Regional Drugs Task Force (RDTF) structures. 
The above reference relates to the Health Board structures details in 
Bulletin 2: Drug Use in Ireland and Northern Ireland 2002/2003 Drug 
Prevalence Survey – Health Board (Ireland) & Health and Social Services 
Board (Northern Ireland) Results (Revised) June, 2005. 
comprehensive technical reports containing copies of the 
questionnaires used in each jurisdiction.
The Research Advisory Group (RAG) decided to change from 
using a pen and paper interviewing technique to computer-
assisted personal interviewing (CAPI), where the interviewer 
records responses electronically. This technique has several 
advantages: interviews can be administered more quickly; human 
error is minimised, yielding higher-quality data; and data input is 
managed more efficiently, thus cutting costs.2
As with other European surveys, people over the age of 64 are 
excluded from this survey, as they grew up in an era when both 
the use and availability of illegal drugs were very limited. 
Therefore surveys with older people have, to date, shown very 
low rates of use even on a lifetime basis. This situation will 
change over time as the younger population grows older. Hence, 
lifetime prevalence rates are likely to increase for a considerable 
period of time. When examining the data and comparing results 
over time, last year use is the best reflection of change as it 
refers to recent use. Last month use is equally valuable as it 
refers to current use.
What is Prevalence?
The term prevalence refers to the proportion of a population 
who has used a drug over a particular time period. In 
general population surveys, prevalence is measured by 
asking respondents in a representative sample drawn from 
the population to recall their use of drugs. The three most 
widely used recall periods are: lifetime (ever used a drug), 
last year (used a drug in the last twelve months), and last 
month (used a drug in the last 30 days). Provided a sample 
is representative of the total population, prevalence 
information obtained from a sample can be used to infer 
prevalence in the population.
Lifetime prevalence refers to the proportion of the sample 
that reported ever having used the named drug at the time 
they were surveyed. A person who records lifetime 
prevalence may – or may not – be currently using the drug. 
Lifetime prevalence should not be interpreted as meaning 
that people have necessarily used a drug over a long period 
of time or that they will use the drug in the future.
Last year prevalence refers to the proportion of the sample 
that reported using a named drug in the year prior to the 
survey. For this reason, last year prevalence is often referred 
to as recent use.
Last month prevalence refers to the proportion of the 
sample that reported using a named drug in the 30 day 
period prior to the survey. Last month prevalence is often 
referred to as current use. A proportion of those reporting 
current use may be occasional (or first-time) users who 
happen to have used in the period leading up to the survey 
– it should therefore be appreciated that current use is not 
synonymous with regular use.
2 EMCDDA Handbook on Population Surveys.
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Understanding the Results  
in this Bulletin
First results from the second Drug Prevalence Survey were 
published in Bulletin 1 (January 2008). They gave lifetime, last 
year and last month prevalence rates for key drugs for the Island 
of Ireland, Ireland and Northern Ireland. Bulletin 2, published in 
June 2008, contained comparable information for Ireland and its 
constituent Regional Drugs Task Force areas (former Health 
Board areas) and Northern Ireland and its constituent Health and 
Social Services Board areas.
Bulletin 4 (2006/7 Drug Prevalence Survey: Cocaine Results) 
published in October 2008, contained prevalence rates for the 
use of cocaine and examined age of first use, regular use, and 
method of taking cocaine, ease of obtaining cocaine, reasons for 
stopping use, perceptions of risk together with the typical profile 
of cocaine users.
This bulletin (Bulletin 3) contains prevalence rates for the use of 
cannabis and other information relating to cannabis use in 
Ireland and Northern Ireland for 2006/7 and also provides 
comparison information between 2002/3 and 2006/7. Results 
are given for all respondents, and are also presented by gender 
and by age (young adults aged 15-34 and older adults aged  
35-64).
Readers should note that the total sample size for each group is 
given at the head of each column. All prevalence rates presented 
in the accompanying tables are rounded to one decimal place 
and are rounded to whole numbers in the text (except for 
percentages less than 1%). Changes in prevalence rates 
between 2002/3 and 2006/7 are also rounded to one decimal 
place and reported in this format in the text.
As in all sample surveys, the greater the sample size the more 
statistically reliable are the results. Some of the differences in 
prevalence rates in the tables will be attributable to natural 
sample variations. Detailed confidence intervals for all prevalence 
rates contained in this bulletin can be found on the websites of 
the NACD and DHSSPS in Bulletin 1 and 2.
Invalid responses have been excluded from all analyses. 
Percentages may not always sum to 100 due to either the effect 
of rounding or where respondents could give more than one 
answer.
Where the figure 0.0% appears it does not mean that no-one 
has used the drug, rather it means that in this category no 
respondent reported use. The confidence intervals will provide a 
prevalence rate for all categories of drug use reported for 
lifetime, last year and last month, by gender and by age. Details 
regarding the calculation of confidence intervals can be found in 
the Technical Report published on the NACD and DHSSPS 
websites.
Two statistical tests were used to examine the relationship 
between cannabis use and other variables such as age, gender, 
economic status and the study year.
The Chi-Square test examined the association between 
categorical variables and cannabis use in 2006/7.  For the 
purposes of this study, a p-value of less than 0.05 indicated that 
a true association or relationship existed and the differences 
observed were not due to chance. The Z-Test was used to 
compare differences in the proportions for selected variables, for 
example ‘how cocaine was obtained’ between 2002/3 and 
2006/7.  
In an attempt to compare prevalence rates for cannabis use 
across different social classes/socio-economic groups, the 
Standard Occupational Classification (SOC2000) was used in 
Ireland. The SOC2000 is based on the employment status, level 
of responsibility and qualifications, of the chief income earner 
within a household. Respondents were then coded into social 
grades.
SOC2000 Classification
A Professionals, senior management and top civil servants
B Middle management, senior civil servants, managers and 
owners of business
C1 Junior management and owners of small businesses
C2 Skilled manual workers and manual workers responsible for 
other workers
D Semi-skilled and unskilled manual workers, trainees and 
apprentices
E All those dependent on the State long-term
Respondents were coded into the following social grades in 
Northern Ireland based on the National Statistics Socio-Economic 
Classification (NSSEC) as this has replaced the Social Class 
based on Occupation and Socio-Economic Group (SEG). The 
NSSEC classification data shown in Table 37 relate to the 
individual.
NSSEC Classification
n	Managerial and professional occupations
n	Intermediate occupations
n	Small employers and own account workers
n	Lower supervisory and technical occupations
n	Semi-routine and routine occupations
n	Never worked and long-term unemployed.
Some of the tables for Ireland (Tables 15-17, 19) and Northern 
Ireland (Tables 37-40) differ slightly with regard to response 
categories. Table 18: Ireland Age Education Ceased has no 
comparable table in Northern Ireland.
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Glossary
Bong
A water pipe through which the hot smoke is cooled down 
before being inhaled.
Grass/Weed
Slang terms for herbal cannabis.
Resin
Produced by separating the resinous parts of the plant from 
the leaves etc.
Hash, Hashish
Cannabis resin.
Hash Oil
A purified and concentrated form of resin or herbal 
cannabis.
Herb
The fresh or (more commonly) dried leaves and flowering 
tops of the plant.
Joint
A cannabis cigarette (also known as a spliff, reefer etc.).
Skunk
A type of high-potency herbal cannabis.
Results – Ireland
Prevalence of Cannabis Use (Table )
More than one-in-five respondents (22%) aged 15-64 reported 
the lifetime use of cannabis; 6% reported use in the last year 
and 3% reported last month use.
Results comparison with 2002/ survey
Since the previous survey, there was a significant increase among 
all adults aged 15-64 in the lifetime use of cannabis (from 
17.4% to 21.9%). Last year use of cannabis increased among all 
adults aged 15-64 from 4.5% in 2002/3 to 6.3% in 2006/7.
Age (Table )
Young adults reported higher cannabis prevalence rates than 
older adults across all three time periods. The lifetime prevalence 
rate for young adults aged 15-34 years was 29% compared with 
16% for older adults aged 35-64 years. The last year prevalence 
rate for young adults aged 15-34 (10.4%) was four times the 
rate for older adults aged 35-64 (2.6%), while last month 
prevalence rate for young adults (4.2%) was more than three 
times that for older adults (1.2%).
Results comparison with 2002/ survey
Since the previous survey in 2002/3, significant increases in the 
lifetime use of cannabis were found among both young adults 
aged 15-34 years (from 24.0% to 28.6%) and older adults aged 
35-64 years (from 11.4% to 16.1%).
Gender (Table )
Male respondents reported higher cannabis prevalence rates than 
females across all three time periods. The lifetime prevalence rate 
for males was 27% compared with 17% for females. The last 
year cannabis prevalence rate for males (9%) was more than 
double that for females (4%) and the last month prevalence rate 
for males (4%) was four times the rate for females (1%).
Results comparison with 2002/ survey
Since the previous survey in 2002/3, significant increases in the 
lifetime use cannabis were found among both males (from 
22.4% to 27%) and females (from 12.3% to 16.6%).
First use (Table 2)
The average age that respondents reported first use of cannabis 
was 18 years3 - this was true for both males and females, and 
young adults aged 15-34 years. Older adults aged 35-64 reported 
an older average3 age of first use (20 years). Regular cannabis 
users reported a younger average age of first use (17 years).
3 The median was used to measure central tendency in the case of the 
age of first use to avoid extreme values skewing the results. 
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Results comparison with 2002/ survey
In the previous survey, the average3 ages of first use of cannabis 
were broadly similar, except for young adults aged 15-34 – they 
reported a younger average3 age of first cannabis use (17 years) 
in the 2002/3 survey.
First regular use (Table 2)
The average3 age of first regular use of cannabis was 18 years – 
this was true for young adults, and males and females. Older 
adults reported an average age of 20 years for first regular use  
of cannabis.
The period of time between first using cannabis and becoming a 
regular user (lag4) was two years in all instances.
Results comparison with 2002/ survey
In the previous survey, the average3 ages of first regular use of 
cannabis were similar, however, females and young adults 
reported first regular use at a younger age (17 years). The lag 
between first use and becoming a regular user was the same 
(two years).
Frequency of use (Table )
More than one-third (37%) of current cannabis users reported 
taking the drug less than once a week in the previous month; 
28% reported cannabis use at least once a week (4-9 days) and 
10% reported use several times a week. Approximately one-in-
four (24%) current cannabis users reported daily or almost  
daily use.
Similarly, one-third of male current users (34%) reported taking 
cannabis less than once a week; 29% reported using the drug at 
least once a week (4-9 days) and a similar proportion reported 
daily or almost daily use (28%). Among female respondents, 
approximately half (49%) of current users reported taking 
cannabis less than once a week, 24% reported use at least once 
a week and 12% reported daily or almost daily use.
Among young adults aged 15-34 years 37% of current cannabis 
users reported taking the drug less than once a week; 27% 
reported cannabis use at least once a week and one-in-four 
(25%) current users reported daily or almost daily cannabis use. 
Among older adults aged 35-64 years, one-in-three (33%) 
current cannabis users reported taking the drug at least once a 
week and 22% reported daily or almost daily use.
Results comparison with 2002/ survey
In the previous survey, male current cannabis users were more 
likely to report use less than once a week (41%) than in this 
survey, and they were less likely to report weekly use (20%). A 
similar proportion reported daily or almost daily use (27%) in 
2002/3 as in 2006/7. Conversely, female current cannabis users 
4 Lag was calculated by measuring the time in years between when a 
respondent reported first using cannabis and first using cannabis regularly.
in 2002/3 were less likely to report use less than once a week 
(40%). Older adults were more likely to have reported use as 
less than once per week in 2002/3 (50%) than in this survey, 
however a similar proportion (21%) reported daily or almost 
daily use in 2002/3 and in 2006/7. These apparent changes 
since 2002/3 were not statistically significant.
Type of cannabis used (Table )
Hash was the most commonly used form of cannabis; 54% of 
current cannabis users aged between 15-64 years reported using 
hash and 6% reported using cannabis resin. More than one-in-
four (27%) current cannabis users reported using grass; an 
additional 8% reported using ‘weed’, 2% reported using ‘herb’ 
and 1% reported using skunk.
One-in-two (50%) male cannabis users reported using hash; as 
did the majority (66%) of female cannabis users.
However, women were less likely than men to report the use of 
grass (23% compared to 28%) and weed (3% compared to 
10%). Female cannabis users were also less likely to know what 
form of the drug they used compared to their male counterparts 
(3% compared to 0%).
Older adults aged 35-64 years (13%) were approximately three 
times more likely to report using resin than young adults aged 
15-34 years (4%), conversely young adults were more likely to 
identify weed as their most commonly use form of cannabis 
than older adults (11% compared to 0%). Only older adults 
aged 34-65 years (3%) and males (1%) reported using  
hash oil.
Results comparison with 2002/ survey
As the coding of responses changed since the last survey, 
statistical comparisons cannot be made, however, it is worth 
noting that the proportions reporting the use of grass were 
substantially lower in 2002/3 among all adults aged 15-64 
(18%), among males (19%), females (16%) and young adults 
(16%).
Smokers of herbal cannabis and whether it 
was grown in Ireland (Table )
Respondents who report current cannabis use and smoked 
herbal cannabis (in the form of grass, weed, herb or skunk) were 
asked whether the cannabis they smoked in the last month was 
grown in Ireland. More than half (51%) of respondents stated 
that the cannabis they smoked was not grown in Ireland, 
whereas 16% reported that it was. One-in-three respondents did 
not know where the cannabis they smoked was grown. Older 
adults aged 35-64 years were four times more likely than young 
adults to report smoking Irish grown cannabis (43% compared 
to 11%). Female respondents were more likely than males to 
state that they did not know whether the cannabis they smoked 
was grown in Ireland (54% compared to 29%).
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Method by which cannabis is used (Table 6)
The vast majority of current users (93%) reported smoking 
cannabis in a joint; an additional 4% reported smoking it in a 
pipe, 3% smoked it in a bong and 0.8% reported eating it. A 
higher proportion of females (96%) reported smoking cannabis 
in a joint than males (92%). Conversely, males were more likely 
than females to smoke it in a pipe (5% compared to 0%) or a 
bong (3% compared to 0%). Older adults aged 35-64 years 
were more likely than young adults aged 15-34 to smoke 
cannabis in a pipe (4% compared to 3%) or in a bong (4% 
compared to 2%). Only females (4%) and young adults aged 
15-34 years (1%) reported eating cannabis.
Results comparison with 2002/ survey
As the coding of responses changed since the last survey, 
statistical comparisons cannot be made. However, in the 
previous survey the vast majority of respondents (98%) also 
reported smoking cannabis in a joint.
How cannabis was obtained (Table 7)
All respondents who reported using cannabis in the last twelve 
months were asked how they had obtained the drug on the last 
occasion. The majority of respondents were either given the drug 
by a family member or friend (44%) or shared the drug 
amongst friends (28%). More than one-in-five respondents 
(22%) reported having bought the drugs from either a friend 
(15%), a contact not known personally (6%) or a stranger (1%).
Generally, male respondents were more likely than females to 
report having bought cannabis; males were more than twice as 
likely as females to have bought the drug from a friend (18% 
compared to 6%); the same proportion of males and females 
reported buying the drug from a contact not known personally 
(6%), and 1% of males bought cannabis from a stranger, 
whereas no females did. Conversely, females were more likely 
than males to report having shared the drug amongst friends 
(33% compared to 26%) or having been given it by family or 
friends (52% compared to 41%).
Young adults aged 15-34 were twice as likely as older adults 
aged 35-64 to report sharing the drug amongst friends (32% 
compared to 16%). Conversely, older adults aged 35-64 years 
were more likely than young adults to report having been given 
the drug by family or friends (52% compared to 42%).
Results comparison with 2002/ survey
In the previous survey almost one-third (31%) of all adults aged 
15-64 years reported being given cannabis by a family member 
or friend; similar proportions were observed across gender and 
age categories. Among all adults aged 15-64 years one-fifth 
(20%) of recent cannabis users reported buying the drug from a 
friend and 16% reported buying the drug from a contact not 
known personally.
Since the previous survey in 2002/3, among all adults aged 15-
64 years there was a significant increase in the proportion of 
those who were given cannabis by family or friends, and a 
significant drop in the proportion who reported buying cannabis 
from a contact not known personally. These significant changes 
in responses occurred across gender and age categories.
Where cannabis was obtained (Table 8)
Respondents who had recently taken cannabis were asked 
where they had obtained the drug on the last occasion that they 
had used it. Over half (57%) of all respondents reported 
obtaining cannabis at the house of friends, 12% obtained it in 
the street/park, 8% reported getting cannabis in a disco/bar/club 
and 5% ordered the drug by phone.
Male respondents (10%) were three times more likely than 
females (3%) to report obtaining cannabis in a disco/bar/club, or 
to have obtained it in school/college (3% compared to 1% 
respectively) and males were twice as likely as females to have 
ordered the drug by phone (6% compared to 3%). On the other 
hand the majority of females reported obtaining cannabis in the 
house of friends (73%) compared to 50% of males. No females 
reported obtaining cannabis in the office/workplace compared to 
2% of the male respondents. The majority of young adults aged 
15-34 years (58%) and older adults (53%) reported obtaining 
cannabis in the house of friends. Older adults were more likely to 
obtain the drug in the street/park than young adults (17% 
compared to 11%). While similar proportions of young and older 
adults reported obtaining cannabis in their office/workplace (2%), 
young adults aged 15-34 years were twice as likely as older adults 
to obtain the drug in school/college (3% compared to 1.5%).
Results comparison with 2002/ survey
A similar proportion of respondents in the previous survey 
reported obtaining cannabis in the house of a friend (57%) 
however a greater proportion of respondents reported obtaining 
the drug in a disco/bar/club (20%). In addition, in the 2002/3 
survey no respondents reported obtaining cannabis in either the 
office/workplace or school/college.
Since the previous survey in 2002/3, among all adults aged  
15-64 years there was a significant drop in the proportion of 
those who obtained cannabis in a disco/bar/club. This significant 
change in responses also occurred among both male and female 
respondents and young adults.
Ease of obtaining cannabis (Table )
The majority of recent cannabis users (62%) considered it ‘very 
easy’ or ‘fairly easy’ to obtain the drug within a 24-hour period. 
This was true for male (63%) and female respondents (58%), 
and both young (62%) and older respondents (60%). However, 
older adults aged 35-64 years were more than twice as likely as 
young adults to consider it ‘very difficult’ to obtain cannabis 
within a 24-hour period (7% compared to 3%).
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Results comparison with 2002/ survey
In the previous survey a higher proportion of all respondents 
considered it ‘very easy’ or ‘fairly easy’ to obtain cannabis within 
a 24-hour period (79%). On the other hand, in the 2002/3 
survey lower proportions considered it ‘fairly difficult’ (7%) and 
‘very difficult’ (0.6%) to obtain the drug.
Since the previous survey in 2002/3, there was a significant 
drop in the proportions who considered it ‘very easy’ to obtain 
cannabis in a 24-hour period among all adults aged 15-64 years 
and a significant increase in the proportions who considered it 
‘fairly difficult’ and ‘very difficult’ to obtain the drug.
Stopping cannabis use and reasons for 
stopping (Tables 0 & )
Over one-quarter (26%) of all respondents who said that they 
had ever taken cannabis reported using the drug regularly. Male 
cannabis users were more likely than female cannabis users to 
report regular use (31% compared to 18%) similarly young 
adult cannabis users aged 15-34 were more likely than older 
adults cannabis users aged 35-64 to report regular use of the 
drug (30% compared to 19%).
Among all adults, two-thirds of regular cannabis users (66%) 
said that they had stopped taking cannabis, 10% said that they 
had tried to stop but failed and almost one-quarter (24%) had 
never tried to stop.
The same proportion (66%) of male and female regular 
cannabis users reported having stopped taking the drug. 
However, males were more likely than females to have never 
tried to stop (25% compared to 20%) and females were more 
likely than males to report having tried but failed to stop (13% 
compared to 8%).
Older adult regular cannabis users were proportionately more 
likely than young adult regular users to report having stopped 
taking cannabis (73% compared to 64%). Conversely, young 
adult regular users were more likely than older adult regular 
users to have never tried to stop taking cannabis (27% 
compared to 17%).
Among all adult regular users who stopped using cannabis, 
approximately one-third (32%) said that it was because they no 
longer wanted to take the drug, 19% said it was due to health 
concerns and 17% said it was because it was no longer part of 
their social life.
Males were four times more likely than females to say that they 
stopped using cannabis because of the impact on their job/
friends and family (9% compared to 2%) or because they were 
persuaded to stop by friends/family (4% compared to 0%). 
One-in-five males (21%) compared to 13% of females said they 
stopped due to health concerns, while 14% of females said they 
stopped taking cannabis due to pregnancy.
Similar proportions of young (33%) and older adults (31%) said 
they had stopped because they did not want to take cannabis 
anymore; however, older adults (28%) were twice as likely as 
young adults (12%) to say it was no longer part of their social 
life. Conversely, young adults were more likely than older adults 
to say they stopped due to health concerns (20% compared to 
16%) and due to the impact of use on their job/friends and 
family (10% compared to 0%).
Results comparison with 2002/ survey
In 2002/3, a similar proportion of those who had ever used 
cannabis reported taking it regularly (27%). The proportion of 
regular users, who reported never having tried to stop taking 
cannabis (30%), was higher in the previous survey, across 
gender and age group. However, none of the apparent changes 
since 2002/3 were statistically significant.
In the 2002/3 survey, a higher proportion of respondents said 
that they stopped taking cannabis due to the cost of the drug 
(8%) and less available supply (5%) however, as the coding of 
responses changed since the last survey statistical comparisons 
could not be made.
Attitudes towards cannabis use (Table 2)
All those surveyed who had heard of cannabis were asked about 
their attitudes regarding cannabis use. The attitudes of this group 
were then compared with the attitudes of two mutually exclusive 
groups – those who said that they had used cannabis at some 
stage in their lives and those who said that they had never used 
cannabis.
In general, those who had ever used cannabis had more liberal 
views towards the use of cannabis for both medical and 
recreational use than those who had never used.
The majority (71%) of those surveyed felt that cannabis use 
should be permitted for medical reasons. Males and older adults 
aged 35-64 were most likely to agree with the medical use of 
cannabis (73% and 74% respectively). A higher proportion of 
those who had ever used cannabis (87%) agreed with the 
medical use of it than those who had never used the drug 
(67%). This was true across gender and age.
In contrast, only 19% of all respondents agreed that cannabis 
use should be permitted for recreational purposes. Eleven 
percent of those who had never used cannabis agreed that 
recreational use should be permitted, compared to 48% of 
those who had ever used the drug. For both groups, males 
(14% and 52% respectively) were more likely to agree with 
recreational use than females (8% compared to 43%).
Respondents were also asked to rate their level of disapproval to 
the occasional use of cannabis – 82% of respondents who had 
never used cannabis compared to 29% of those who had ever 
used cannabis disapproved of people smoking cannabis 
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occasionally. For both groups females (84% and 32% 
respectively) were more likely to disapprove than males (80% 
and 28%), and older adults (84% and 31% respectively) were 
more likely to disapprove than young adults (79% and 28% 
respectively).
Results comparison with 2002/ survey
Medical reasons 
In 2002/3, a higher proportion (44%) of all respondents ‘fully 
agreed’ that cannabis use should be permitted for medical 
reasons. Similarly, the proportions of respondents who had never 
used cannabis (42%) and who had ever used cannabis (72%), 
who ‘fully agreed’ that cannabis use should be permitted for 
medical use, were higher in the previous survey than in 2006/7. 
These changes were statistically significant.
Recreational reasons 
In 2002/3, a higher proportion (9%) of respondents ‘fully 
agreed’ that cannabis use for recreational reasons should be 
permitted. The proportions of respondents who had never used 
cannabis (4%) and who had ever used cannabis (32%), who 
‘fully agreed’ that cannabis should be permitted for recreational 
use, were higher in the previous survey than in 2006/7. These 
changes were statistically significant across gender and age 
categories among those who had ever used cannabis and for 
males and young adults in the general population.
Smoking cannabis occasionally 
In 2002/3, a lower proportion (33%) of all respondents ‘strongly 
disapproved’ of the occasional use of cannabis. Similarly, the 
proportions of respondents who had never used cannabis 
(39%) and who had ever used cannabis (4%), who ‘strongly 
disapproved’ of occasional cannabis use, were lower in the 
previous survey than in 2006/7. These changes were statistically 
significant across gender and age categories among those who 
had never used cannabis, and among females and young adults 
in the general population.
Risk perceptions (Table 2)
When asked about the risk involved in the use of the drug, 
approximately two-in-three (68%) respondents who had never 
used cannabis compared to less than one-third (30%) of 
respondents who had ever used cannabis, felt that there was a 
great risk in smoking cannabis regularly.
Males and females who had never used cannabis were more 
than twice as likely (63% and 73% respectively) as males and 
females who had ever used cannabis (28% and 33% 
respectively) to perceive cannabis use as a ‘great risk’. In general, 
males were less likely to perceive cannabis use as a ‘great risk’ 
than females.
Both young adults aged 15-34 years (59%) and older adults 
(75%) who had never used cannabis were proportionately more 
likely to have felt that there was a ‘great risk’ associated with 
regular cannabis use, compared to young (28%) and older 
adults (32%) who had ever used cannabis.
Results comparison with 2002/ survey
In 2002/3, a lower proportion (57%) of all respondents felt that 
there was a ‘great risk’ associated with regular cannabis use. 
Similarly, the proportions of respondents who had never used 
cannabis (64%) and who had ever used cannabis (25%), who 
perceived regular use to be a ‘great risk’, were lower in the 
previous survey than in 2006/7. These changes were statistically 
significant.
Profile of cannabis users
For the purpose of the statistical tests detailed below a cannabis 
user is defined as someone who has ever used cannabis on a 
lifetime basis.
Tests were performed on the data for lifetime, last year and last 
month prevalence rates.
Gender (Table )
The results of the three chi-square tests were statistically 
significant. This indicated that there is an association between 
gender and cannabis use. Males were proportionately more likely 
than females to have ever used cannabis, to have used it in the 
last twelve months, and to report current use of the drug.
Results from the 2002/ survey found the same 
association between gender and cannabis use.
Age (Table )
The results of the three chi-square tests were statistically 
significant. This indicated that there is an association between 
age and cannabis use. Young adults aged 15-34 were 
proportionately more likely than older adults aged 35-64 to 
report lifetime, last year and current (last month) cannabis use.
Results from the 2002/ survey found the same 
association between age and cannabis use.
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Socio-economic group (Table )
The results of the three chi-square tests were statistically 
significant. This indicated that there is an association between 
socio-economic group (SEG) and cannabis use for lifetime, last 
year and last month use. Respondents from the SEG C1 (junior 
management and owners of small businesses) had higher 
lifetime, last year and last month cannabis prevalence rates than 
expected, whereas respondents in the SEG C2 (skilled manual 
workers and manual workers responsible for other work) and 
SEG B (middle management, senior civil servants, managers and 
owners of businesses) had lower lifetime, last year and last 
month prevalence rates than expected. Respondents from the 
SEG D (semi-skilled and unskilled manual workers, trainees and 
apprentices) had higher last year and last month cannabis 
prevalence rates than expected.
Results from the 2002/ survey found an  
association between SEG and lifetime and  
last month cannabis use.
Work status (Table 6)
The results of the two chi-square tests were statistically 
significant. This indicates that there was an association between 
work status and lifetime and last year cannabis use. Respondents 
who were in paid work had a higher lifetime prevalence rate 
than expected, whereas respondents who were not in paid work 
had a lower lifetime and last year prevalence rate than expected. 
Students had a higher last year cannabis prevalence rate than 
expected.
Results from the 2002/ survey found similar 
associations between work status and cannabis use.
Housing tenure (Table 7)
The results of the three chi-square tests were statistically 
significant. This indicated that there is an association between 
housing tenure and cannabis use. Respondents who rented 
property from a private landlord had a higher lifetime, last year 
and last month cannabis prevalence rate than expected, whereas 
respondents who owned their home had a lower lifetime, last 
year and last month prevalence rate than expected.
Results from the 2002/ survey found the same 
associations between housing tenure and cannabis use.
Age education ceased (Table 8)
The results of the two chi-square tests were statistically 
significant. This indicates that there is an association between 
lifetime and last year prevalence rates and age education ceased. 
Respondents who left education aged 20 years or older had a 
higher lifetime and last year prevalence rate than expected, 
whereas respondents who left education aged 15 years and 
younger had a lower lifetime and last year prevalence rate than 
expected.
Results from the 2002/ survey found an association 
between age education ceased (20 years or older) and 
lifetime cannabis use.
Education level (Table )
The results of the two chi-square tests were statistically 
significant. This indicates that there is an association between 
lifetime and last year prevalence rates and education level 
attained. Respondents who had an elementary and lower second 
level education had lower lifetime and last year prevalence rates 
than expected. Respondents who had upper level secondary 
education had higher lifetime and last year prevalence rates than 
expected and those who had third level education had a higher 
lifetime prevalence rate than expected.
Results from the 2002/ survey found this association 
only with third level education and lifetime prevalence.
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Results – Northern Ireland
Prevalence of cannabis use (Table 2)
One-quarter of respondents (25%) aged 15-64 reported that 
they had taken cannabis at some stage in their lives, with 7% 
having used in the last year and 3% having used in the last 
month.
Results comparison with 2002/ survey
Since the previous survey, there were significant increases among 
all adults aged 15-64 in the lifetime (from 16.8% to 24.7%) 
and in the last year (from 5.4% to 7.2%) use of cannabis. There 
was no statistically significant change in the current cannabis 
prevalence rate among all adults.
Age (Table 2)
Overall, cannabis prevalence rates were higher among young 
adults across all time periods. The lifetime prevalence for young 
adults aged 15-34 (35%) was double the rate for older adults 
aged 35-64 (17%) while the last year prevalence rate for young 
adults (12%) was four times that for older adults (3%). The rate 
of last month use of cannabis for those aged 15-34 (4%) was 
twice that for those aged 35-64 (2%).
Results comparison with 2002/ survey
Since the previous survey in 2002/3, significant increases in the 
lifetime use of cannabis were found among both young adults 
aged 15-34 years (from 25.1% to 35.0%) and older adults aged 
35-64 years (from 10.3% to 17.3%). A significant increase was 
also found among older adults aged 35-64 years in their last 
year use of cannabis where prevalence increased from 2.0% to 
3.3% between 2002/3 and 2006/7.
Gender (Table 2)
Male respondents reported higher cannabis prevalence rates 
than females across all time periods. The lifetime prevalence rate 
for males was 30% compared to 19% for females. The last year 
prevalence rate for males (10%) was more than double that for 
females (4%) while last month prevalence rates for males and 
females were 4% and 2%, respectively.
Results comparison with 2002/ survey
Since the previous survey in 2002/3, significant increases in the 
lifetime use of cannabis were found among both males (from 
23.3% to 30.1%) and females (from 10.5% to 19.3%). 
Females also showed a significant increase in last year cannabis 
use (from 2.2% to 4.1%).
First use (Table 2)
For respondents who had ever taken cannabis, the average age 
that they had first used cannabis was reported as 18 years.5 
Females were slightly older at 19 years compared to males at 18 
years. Young adults aged 15-34 reported a lower average5 age of 
first use (17 years) while older adults aged 35-64 reported an 
average age of first use of 20 years.
The average5 age that regular users reported they had first used 
cannabis was 16 years. This was also true for males, females and 
young adults. However, among older adults who are regular 
users, the average age that they first used cannabis was higher at 
19 years.
Results comparison with 2002/ survey
Among all users of cannabis, the average5 age of first use has 
remained unchanged since 2002/3 for all adults, males, females 
and young adults. However, older adults aged 35-64 reported a 
higher average age of first use of cannabis (21 years) in the 
previous survey.
Among regular users of cannabis, the average5 age of first use 
has remained unchanged since the previous survey for all adults, 
males and young adults. In 2002/3, females and older adults 
aged 35-64 reported a higher average age of first use of 
cannabis (17 years and 20 years respectively).
First regular use (Table 2)
Among regular users, the average5 age of first regular use of 
cannabis was reported as 18 years – this was also true for males 
and females. The average age of first regular use, for young 
adults aged 15-34 was reported as 17 years, compared to an 
average age of 21 years for those aged 35-64.
The period of time between first using cannabis and becoming a 
regular user (lag6) was two years for all adults, males and 
females. However, the lag for young adults aged 15-34 was one 
year compared to three years for older adults.
Results comparison with 2002/ survey
In the previous survey, the average5 age of first regular use of 
cannabis was similar, although females, young adults and older 
adults reported first regular use at an older age (19 years for 
females, 18 years for younger adults and 23 years for older 
adults).
The lag between first use and becoming a regular user was the 
same for all groups of respondents (two years) except for 
females where it was one year in 2002/3.
5 The median was used to measure central tendency in the case of age of 
first use to avoid extreme values skewing the results.
6 Lag was calculated by measuring the time in years between when a 
respondent reported first using cannabis and first using cannabis regularly.
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Frequency of use (Table 2)
Almost two-fifths (38%) of current cannabis users reported taking 
the drug less than once a week in the previous month while just 
over one-quarter (27%) used cannabis at least once a week.
Approximately one-in-six (16%) said that they used cannabis on 
a daily or almost daily basis. However, when broken down by 
gender, almost one-quarter of males (24%) compared to no 
females reported using cannabis on a daily or almost daily basis.
Of current users, one-in-eight (12%) young adults compared to 
23% of older adults reported taking cannabis on a daily or 
almost daily basis.
Results comparison with 2002/ survey
Results from the previous survey in 2002/3 were broadly similar 
with regard to the frequency of use of cannabis; there were no 
significant differences between the two years among any of the 
groups of respondents.
Type of cannabis used7 (Table 26)
Grass was the most commonly used form of cannabis among 
current users, reported by 43% of all adults aged 15-64. Grass 
was also the most common type used by females (67%) and 
young adults (54%) while resin was the most common type 
used by males (44%) and older adults (41%).
Results comparison with 2002/ survey
The proportions reporting the use of grass were significantly lower 
among all adults aged 15-64 (15%), among males (12%), 
females (29%) and young adults (15%) in the previous survey.
Conversely, the proportions reporting the use of hash in the 
2002/3 survey were significantly higher among all adults aged 
15-64 (28%), males (30%) and young adults (28%). Use of 
the herbal form of cannabis by older adults was significantly 
higher in 2002/3 with 18% reporting use in this form.
Smokers of cannabis and whether it was 
grown in Northern Ireland (Table 27)
Respondents who were current users and smoked cannabis in 
the form of grass, weed, herb or skunk were asked whether the 
cannabis was grown in Northern Ireland. Almost one-third (31%) 
stated that the cannabis was grown in Northern Ireland and the 
same proportion reported that it was not. The remaining 38% 
did not know where the cannabis was grown.
Just over two-fifths (41%) of males said that the cannabis was 
grown in Northern Ireland while almost half (47%) of females 
did not know. One-quarter (25%) of young adults reported that 
the cannabis was grown in Northern Ireland compared to almost 
half (47%) of older adults.
7 This was a multi-choice question in 2002/3 but not in 2006/7.
Method by which cannabis is used8 (Table 28)
Current users were asked about how they take cannabis and 
85% reported that they take cannabis in the form of a joint. This 
was true for both male (92%) and female (70%) respondents 
and for young adults (78%) and older adults (96%).
Results comparison with 2002/ survey
Results from the previous survey in 2002/3 were broadly similar 
with regard to the method of use of cannabis; there were no 
significant differences between the two surveys among any of 
the groups of respondents.
How cannabis was obtained (Table 2)
All respondents who said they had used cannabis in the last 
twelve months were asked how they had obtained the drug on 
the last occasion. More than one-third (35%) said they shared 
cannabis among a group of friends, a further 30% reported that 
they were given the drug by family/friends and 18% reported 
that they bought the cannabis from a friend.
Less than two-fifths (37%) of females compared to over one-
quarter of males (28%) had been given the cannabis by family/
friends. Similar proportions of females (36%) and males (35%) 
shared cannabis among friends, while 23% of males compared 
to 5% of females had bought it from a friend. Over one-tenth 
(13%) of females had bought the cannabis from a contact not 
known personally, compared to 2% of males.
Almost two-in-five young adults (39%) said that they shared 
cannabis among a group of friends, one-third (33%) had been 
given the cannabis by family/friends and a further 15% had bought 
it from a friend. Approximately one-quarter of older adults reported 
the drug had been bought from a friend (27%), been shared 
among friends (25%) or been given by family/friends (23%).
Results comparison with 2002/ survey
In the previous survey one-fifth (20%) of all adults aged 15-64 
years reported being given cannabis by a family member or 
friend; similar proportions were observed across the gender and 
older adult categories although a significantly lower proportion of 
young adults (19%) were given cannabis by a family member or 
friend in 2002/3.
In the previous survey a significantly higher proportion of females 
(22%) reported buying cannabis from a friend; similar proportions 
were observed among males and across the age categories.
Since the previous survey in 2002/3, there was a significant 
drop in the proportion of young adults aged 15-34 years who 
were given cannabis by a stranger; similar proportions were 
observed among males, females and older adults.
8 This was a multi-choice question in 2002/3 but not in 2006/7.
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Where cannabis was obtained (Table 0)
Respondents who had recently taken cannabis were asked 
where they had obtained the drug. Over half (56%) said they 
had obtained cannabis at the house of friends, while 17% had 
obtained it at a disco/bar/club, 9% in the street/park, 6% at the 
house of a dealer and 5% had ordered it by phone.
Just over three-fifths of females (61%) compared to 54% of 
males had obtained cannabis at the house of friends and 
approximately one-fifth of male respondents (19%) compared to 
one-in-ten female respondents (10%) obtained cannabis in a 
disco/bar/club. Thirteen percent of female respondents and 7% 
of male respondents reported obtaining cannabis in a street/
park, while 6% of males and 4% of females said that they 
obtained cannabis by ordering it by phone.
Nearly three-fifths of young adults (59%) compared to almost 
half (49%) of older adults said that they had obtained cannabis 
at the house of friends. More than twice as many young adults 
(28%) compared to older adults (13%) reported obtaining 
cannabis at a disco/bar/club.
Results comparison with 2002/ survey
Results from the previous survey in 2002/3 were broadly similar 
with regard to where cannabis was obtained; there were no 
significant differences between the two surveys among any of 
the groups of respondents.
Ease of obtaining cannabis (Table )
Of recent users, the majority (75%) of respondents considered it 
‘very easy’ or ‘fairly easy’ to obtain cannabis within a 24-hour 
period. This was true for both male (77%) and female (71%) 
respondents and for both young adults (77%) and older adults 
(70%).
Results comparison with 2002/ survey
Since the 2002/3 survey, the proportion of all adults considering 
it ‘very easy’ or ‘fairly easy’ to obtain cannabis within a 24-hour 
period has fallen significantly from 91%. The proportions of 
males, young adults aged 15-34 and older adults aged 35-64 
considering cannabis ‘very easy’ or ‘fairly easy’ to obtain in a  
24-hour period have also decreased significantly from 2002/3.
Conversely, there were significant increases in the proportions of 
all adults aged 15-64, males and young adults aged 15-34 who 
considered it ‘fairly difficult’ or ‘very difficult’ to obtain the drug in 
a 24-hour period, since 2002/3.
Stopping cannabis use and reasons for 
stopping (Tables 2 & )
Almost one-quarter (24%) of respondents who had ever taken 
cannabis said that they had used it regularly. Of these regular 
users, almost three-quarters (74%) said that they had stopped 
taking cannabis, 13% said that they had tried to stop but failed 
while another 13% said that they had never tried to stop.
Approximately three-quarters of both female respondents (75%) 
and male respondents (74%) said that they had stopped taking 
cannabis, 16% of females and 11% of males had tried to stop 
but failed, while 15% of males compared to 9% of females said 
that they had never tried to stop.
More than three-quarters of young adults (77%) compared to 
more than two-thirds of older adults (68%) said that they had 
stopped taking cannabis, while 18% of older adults and 10% of 
young adults had tried to stop but failed, compared to 14% of 
older adults and 13% of young adults who said that they had 
never tried to stop.
Over one-third of regular users (36%) who stopped using 
cannabis said they stopped because they did not want to take it 
any more. Almost one-quarter (24%) said they stopped because 
cannabis was no longer part of their social life, 9% cited health 
concerns as their reason for stopping and 9% said they stopped 
using cannabis due to the cost/they could no longer afford it.
Just over two-fifths of females (41%) compared to just over one-
third of males (34%) who had stopped taking cannabis said 
they did not want to take it any more. More than one-quarter of 
females (27%) compared to almost one-quarter of males 
(24%) stopped taking cannabis because it was no longer part of 
their social life, while 9% of females and 6% of males did not 
enjoy the after effects. Around one-in-ten males (11%) stopped 
taking cannabis because of the cost/they could no longer afford 
it compared to 4% of females.
Almost two-in-five young adults (39%) compared to almost 
three-in-ten older adults (29%) stated the reason for stopping 
was that they did not want to take it any more. Almost two-fifths 
(39%) of older adults said they stopped using cannabis as it was 
no longer part of their social life, compared to 19% of young 
adults.
Results comparison with 2002/ survey
In the previous survey, the proportion of all adults aged 15-64  
who were regular users and had stopped taking cannabis (48%) 
was significantly lower. A significantly higher proportion in 
2002/3 had never tried to stop (33%).
The proportions of males and young adults aged 15-34 who 
stopped taking cannabis have increased significantly since 
2002/3, although there was a decrease in the proportions of 
males and young adults who had tried to stop but failed and 
who had never tried to stop taking cannabis. In 2002/3, a 
significantly lower proportion of females (29%) had never tried 
to stop taking cannabis.
In 2002/3, the proportions of all adults aged 15-64 (26%), 
males (31%) and young adults aged 15-34 (29%) stating 
‘health concerns’ as the reason for stopping taking cannabis were 
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significantly higher. Also, in the previous survey, significantly 
higher proportions of all adults (20%) and young adults (25%) 
reported the reason for stopping taking cannabis as ‘did not 
enjoy the after effects’. 
In the previous survey, a significantly higher proportion of young 
adults aged 15-34 cited ‘pros did not outweigh the cons’ (10%) 
as the reason for stopping taking cannabis and a significantly 
higher proportion of older adults aged 35-64 said they ‘did not 
want to take it any more’ (66%).
Similar proportions of females, in both surveys, had reported 
each of the reasons for stopping taking cannabis.
Attitudes towards cannabis use (Table )
All those surveyed who had heard of cannabis were asked about 
their attitudes regarding cannabis use. The attitudes of this group 
were then compared with the attitudes of two mutually exclusive 
groups - those who said that they have used cannabis at some 
stage in their lives and those who said that they have never used 
cannabis.
In general, those who have ever used cannabis had more liberal 
views on the use of cannabis for both medical and recreational 
use and they felt that there was less risk to those who smoked 
cannabis on a regular basis.
For all respondents surveyed, almost three-quarters (73%) of all 
adults aged 15-64 ‘fully agreed’ or ‘largely agreed’ that people 
should be permitted to take cannabis for medical reasons. Males 
(76%) were more likely than females (69%) to have these 
combined levels of agreement, while similar proportions of 
young adults (72%) and older adults (74%) ‘fully agreed’ or 
‘largely agreed’ with the medical use of cannabis. A higher 
proportion of all adults aged 15-64 who have ever used 
cannabis (88%) ‘fully agreed’ or ‘largely agreed’ with its use for 
medical reasons than all adults who have never used the drug 
(68%). This was true across gender and age.
In contrast, for all respondents surveyed, less than one-fifth 
(18%) of all adults aged 15-64 ‘fully agreed’ or ‘largely agreed’ 
that cannabis should be allowed to be used for recreational 
reasons. Males (22%) were more likely than females (14%), 
and young adults (23%) more likely than older adults (15%), to 
hold these combined levels of agreement. A higher proportion of 
all adults who have ever used cannabis (43%) ‘fully agreed’ or 
‘largely agreed’ with recreational cannabis use than those who 
have never used cannabis (10%). This was true across gender 
and age.
Respondents were also asked to rate their level of disapproval to 
the occasional use of cannabis. For all those surveyed, over two-
thirds (69%) of all adults ‘disapproved’ or ‘strongly disapproved’ 
of people smoking cannabis occasionally. Females (73%) were 
more likely than males (64%), and older adults (75%) were 
more likely than young adults (60%) to have these combined 
levels of disapproval. A higher proportion of all adults who have 
never used cannabis (81%) than those who have used it (32%) 
‘disapproved’ or ‘strongly disapproved’ of people smoking it 
occasionally. This was true across gender and age.
Results comparison with 2002/ survey
Medical reasons 
For all respondents surveyed, in 2002/3 a significantly higher 
proportion of all adults aged 15-64 ‘fully agreed’ (53%) that 
people should be permitted to take cannabis for medical 
reasons. In the previous survey, the proportions of all adults who 
‘largely agreed’ (25%), ‘neither agreed nor disagreed’ (6%) and 
‘largely disagreed’ (6%) with this statement were significantly 
lower than in 2006/7.
For respondents who had never used cannabis, a significantly 
higher proportion of all adults aged 15-64 in the previous survey 
‘fully agreed’ (49%) that people should be permitted to take 
cannabis for medical reasons. In 2002/3, the proportions of all 
adults who ‘largely agreed’ (28%), ‘neither agreed nor disagreed’ 
(6%) and ‘largely disagreed’ (7%) were significantly lower.
For those who had ever used cannabis, a significantly higher 
proportion of all adults aged 15-64 in 2002/3 ‘fully agreed’ 
(80%) that people should be permitted to take cannabis for 
medical reasons. However, in the previous survey, the 
proportions of all adults who ‘largely agreed’ (14%), ‘neither 
agreed nor disagreed’ (3%) and ‘largely disagreed’ (1%) with 
this statement were significantly lower.
Recreational reasons 
For all respondents surveyed, in 2002/3 a significantly higher 
proportion of all adults aged 15-64 ‘fully agreed’ (10%) that 
people should be permitted to take cannabis for recreational 
reasons. In the previous survey, the proportions of all adults who 
‘neither agreed nor disagreed’ (10%) and ‘largely disagreed’ 
(23%) with this statement were significantly lower than in 
2006/7.
For respondents who had never used cannabis, significantly 
higher proportions of all adults aged 15-64 in the previous 
survey ‘fully agreed’ (5%) and ‘largely agreed’ (9%) that people 
should be permitted to take cannabis for recreational reasons. In 
2002/3, the proportion of all adults who ‘neither agreed nor 
disagreed’ (9%) with this statement was significantly lower.
For those who had ever used cannabis, a significantly higher 
proportion of all adults aged 15-64 in 2002/3 ‘fully agreed’ 
(36%) that people should be permitted to take cannabis for 
recreational reasons. However, in the previous survey, the 
proportions of all adults who ‘neither agreed nor disagreed’ 
(13%) and ‘largely disagreed’ (11%) with this statement were 
significantly lower.
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Smoking cannabis occasionally 
For all respondents surveyed, in 2002/3 a significantly higher 
proportion of all adults aged 15-64 ‘strongly disapproved’ (33%), 
and a significantly lower proportion ‘disapproved’ (33%), of 
smoking cannabis occasionally.
For those respondents who had never used cannabis, a 
significantly higher proportion of all adults aged 15-64 in 2002/3 
‘did not disapprove’ (23%) of people smoking cannabis 
occasionally while a significantly lower proportion of all adults 
‘disapproved’ (37%).
For those who had ever used cannabis, in 2002/3 a significantly 
higher proportion of all adults aged 15-64 ‘did not disapprove’ 
(79%), and a significantly lower proportion ‘disapproved’ (15%), 
of people smoking cannabis occasionally than in the 2006/7 
survey.
Risk perception (Table )
When asked about the risk involved in the use of cannabis, 72% 
of all adults who had never used the drug compared to over a 
third (37%) of all adults who had ever used it felt that there was 
a ‘great risk’ in smoking cannabis regularly.
Females and males who had never used cannabis were more 
likely (75% and 67% respectively) than females and males who 
had ever used cannabis (43% and 33% respectively) to 
perceive regular cannabis use as a ‘great risk’. In general, females 
were more likely than males to perceive regular cannabis use as 
a ‘great risk’.
Both older adults (76%) and young adults (63%) who had 
never used cannabis felt that there was a ‘great risk’ from regular 
cannabis use compared to the corresponding respondents (41% 
and 34% respectively) who had ever used cannabis.
Results comparison with 2002/ survey
For all respondents surveyed, in 2002/3 significantly higher 
proportions of all adults aged 15-64 felt that there was ‘no risk’ 
(2%) and a ‘slight risk’ (15%) related to smoking cannabis 
regularly. In the previous survey, a significantly lower proportion 
of all adults felt there was a ‘great risk’ (54%) related to smoking 
cannabis regularly than in 2006/7. 
For those who had never used cannabis, significantly higher 
proportions of all adults aged 15-64 in the previous survey felt 
that there was a ‘slight risk’ (11%) and a ‘moderate risk’ (24%) 
related to smoking cannabis regularly, while a significantly lower 
proportion felt that there was a ‘great risk’ (60%). 
For those who had ever used cannabis, in 2002/3 significantly 
higher proportions of all adults aged 15-64 felt that there was 
‘no risk’ (9%) and a ‘slight risk’ (32%) related to smoking 
cannabis regularly. Conversely, in the previous survey, significantly 
lower proportions of all adults felt there was a ‘moderate risk’ 
(34%) and a ‘great risk’ (23%) than in 2006/7.
Personally know people who take cannabis 
(Tables  & 2)
In 2006/7, almost half (46%) of respondents reported personally 
knowing people who had taken cannabis compared to 
approximately one-third (34%) in 2002/3. Significant increases 
since the previous survey were found among males (from 42% 
to 51%), females (from 26% to 41%), young adults aged 15-34 
(from 50% to 62%) and older adults aged 35-64 (from 22% to 
34%). In both 2002/3 and 2006/7, males were more likely than 
females, and young adults were more likely than older adults, to 
have reported personally knowing people who take cannabis.
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Profile of cannabis users
For the purpose of the statistical tests detailed below a cannabis 
user was defined as someone who has ever used cannabis.
Tests were performed on the data for lifetime, last year and last 
month prevalence rates.
Gender (Table )
The results of three chi-square tests were statistically significant, 
showing an association between gender and cannabis use. 
Males were more likely than females to have ever used 
cannabis, to have used it in the last year and to have used it in 
the last month.
Results from the 2002/ survey found the same 
association between gender and cannabis use.
Age (Table 6)
The results of the three chi-square tests were statistically 
significant. This indicates that there is an association between 
age and cannabis use. Young adults (15-34 years) were more 
likely than older adults aged 35-64 to report lifetime, last year 
and last month use.
Results from the 2002/ survey found the same 
association between gender and cannabis use.
National Statistics Socio-Economic 
Classification (NSSEC) (Table 7)
The results of the three chi-square tests were statistically 
significant. This indicates that there is an association between 
NSSEC and cannabis use. Managerial and professional 
occupations, semi-routine and routine occupations and the 
unemployed had higher than expected lifetime prevalence than 
the other occupations. Small employers and own account 
workers and semi-routine and routine occupations had higher 
than expected recent and current prevalence rates than the other 
occupations.
Results from the 2002/ survey found there to be an 
association between socio-economic group (SEG) and 
cannabis use for both lifetime and last month use.
9 In 2002/3 Socio-Economic Group (SEG) was used in NI.
Work status0 (Table 8)
The result of one of the three chi-square tests was statistically 
significant. This indicates that there is an association between 
work status and lifetime cannabis use, but not between work 
status and recent and current cannabis use. Respondents who 
were in paid work had a lifetime prevalence rate higher than 
expected whereas those respondents who were not in paid work 
had a lower lifetime prevalence rate than expected.
Results from the 2002/ survey found the same 
association between work status and cannabis use.
Housing tenure (Table 6)
The results of the three chi-square tests were statistically 
significant. This indicates that there is an association between 
housing tenure and cannabis use. Respondents who owned their 
own home outright had lower prevalence rates than expected for 
lifetime, last year and last month use, whereas respondents who 
rented their property (rented from Housing Executive, Housing 
Association or privately) had higher prevalence rates than 
expected for lifetime, last year and last month use.
Results from the 2002/ survey found there to be an 
association between renting from a private landlord 
and cannabis use.
Education level (Table 0)
The results of the three chi-square tests were statistically 
significant. This indicates that there is an association between 
levels of education and lifetime, recent or current drug use. 
Respondents who had educational qualifications of GCSE grade 
C or above had higher prevalence rates than expected for 
lifetime cannabis use, whereas respondents who had GCSE 
grade D or below (including those with no qualifications) had 
lower lifetime prevalence rates than expected. Respondents with 
educational qualifications above A level and those with no 
qualifications had lower last year and last month prevalence rates 
than expected, whereas respondents with A levels or GCSEs had 
higher than expected last year and last month prevalence rates.
Results from the 2002/ survey showed that 
respondents who had educational qualifications had 
higher than expected prevalence rates for lifetime, last 
year and last month use, whereas respondents who 
had no qualifications had lower prevalence rates than 
expected.
10 The work status categories used in NI varied slightly between the 2002/3 
and 2006/7 surveys.
11 The housing tenure categories used in NI differed between the 2002/3 
and 2006/7 surveys.
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Ireland and Northern Ireland 
Comparison – Key Findings
Caution should be used when interpreting information based on 
small numbers.
n	Lifetime cannabis prevalence rates among adults aged 15-64 
are higher in Northern Ireland (25%) than in Ireland (22%).
n	Males reported higher prevalence rates than females across 
all time periods in both jurisdictions.
n	Age of first use of cannabis is broadly similar although regular 
users in Northern Ireland first started using at a younger age 
(16 years) than in Ireland (17 years).
n	In Northern Ireland and Ireland, the age of first use of 
cannabis has remained largely unchanged since 2002/3.
n	Hash is the most common type of cannabis used in Ireland, 
while grass is most commonly used in Northern Ireland.   
n	Almost one-in-three (31%) adults aged 15-64 in Northern 
Ireland smoke cannabis that is grown in Northern Ireland, 
compared to approximately one-in-six (16%) adults in 
Ireland who smoke cannabis grown in Ireland. 
n	How cannabis was obtained is broadly similar in both 
jurisdictions. However, a higher proportion of all adults aged 
15-64 were given the cannabis by family/friends in Ireland 
(44%) than in Northern Ireland (30%).
n	The proportion of all adults who obtained cannabis in a 
disco/bar/club is two times higher in Northern Ireland (17%) 
than in Ireland (8%). No-one reported obtaining cannabis in 
a school/college in Northern Ireland compared to 3% of all 
adults in Ireland.
n	A higher proportion of all adults aged 15-64 in Northern 
Ireland (75%) than in Ireland (62%) said it was ‘very easy’ 
or ‘fairly easy’ to obtain cannabis. 
n	The proportions of lifetime users who reported using 
cannabis regularly are similar among all adults in Ireland 
(26%) and Northern Ireland (24%).  Among regular users, a 
higher proportion of all adults had never tried to stop taking 
cannabis in Ireland (24%) than in Northern Ireland (13%). 
n	Both Ireland and Northern Ireland have experienced a shift in 
attitudes since the previous survey, with higher proportions of 
those who have used cannabis attributing great risk to its use 
and disagreeing that people should be allowed to take 
cannabis for recreational reasons.
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Table 1: Ireland
Cannabis Prevalence Rates (%) Cannabis Prevalence Rates (%)
2006/7
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
2002/3
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Total Weighted N (valid responses) (4967) (2513) (2454) (2315) (2652) Total Weighted N (valid responses) (4918) (2470) (2448) (2333) (2585)
Lifetime Prevalence (%) 21.9* 27.0* 16.6* 28.6* 16.1* Lifetime Prevalence (%) 17.4 22.4 12.3 24.0 11.4
Last Year Prevalence (Recent use) (%) 6.3* 8.5 3.9 10.4 2.6 Last Year Prevalence (Recent use) (%) 4.5 7.2 2.9 8.6 1.8
Last Month Prevalence (Current use) (%) 2.6 4.0 1.1 4.2 1.2 Last Month Prevalence (Current use) (%) 2.6 3.4 1.7 4.3 0.9
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
*Indicates a significant change from 2002/3 to 2006/7
21 National Advisory Committee on Drugs (NACD) & Public Health Information and Research Branch (PHIRB) December 2008
Drug Use in Ireland & Northern Ireland 2006/2007 Drug Prevalence Survey: Cannabis Results Bulletin 3
Table 2: Ireland
 Age of First Use and First Regular Use of Cannabis
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Age first use cannabis (all users) 
Total Weighted N (valid responses) (1087) (679) (408) (661) (426)
Mean age of first use 20 20 19 18 22
Median of age of first use1 18 18 18 18 20
Age first use cannabis (regular users)
Total Weighted N (valid responses) (280) (208) (72) (201) (79)
Mean age of first use 17 18 17 17 19
Median of age of first use1 17 17 17 17 19
Age first regular use cannabis (regular users)
Total Weighted N (valid responses) (280) (208) (72) (201) (79)
Mean age of first use 19 19 19 18 21
Median of age of first use1 18 18 18 18 20
Average number of years between first use and first regular use of cannabis (regular users)2
Total Weighted N (valid responses) (276) (205)◆ (72)◆ (198)◆ (79)◆
Average number of years 2 2 2 2 2
1 Median is used as a measure of central tendency to avoid extreme values skewing results.
2 Lag was calculated by measuring the time in years between when a respondent reported first using cannabis and first using cannabis regularly.
◆ Due to rounding, the weighted Ns for the gender or age categories do not always sum to the total weighted N.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
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Table 3: Ireland
Frequency of Cannabis Use1 (Current Users) (%) Frequency of Cannabis Use1 (Current Users) (%) 
2006/7
All 
adults
15-64
Male Female
Young 
adults
15-34
Older 
adults
35-64
2002/3
All 
adults
15-64
Male Female
Young 
adults
15-34
Older 
adults
35-64
Frequency of use (%) Frequency of use (%)
Total Weighted N (valid responses) (128) (99)◆ (28)◆ (97) (31) Total Weighted N (valid responses) (125) (84) (41) (100)◆ (24)◆
20 days or more 24.4 27.8 12.3 25.0 22.4 20 days or more 22.2 27.4 11.3 22.5 20.7
10-19 days 10.3 9.0 15.0 11.1 7.9 10-19 days 14.0 10.4 21.5 14.9 10.2
4-9 days 28.3 29.4 24.1 26.9 32.6 4-9 days 22.3 19.9 27.1 23.0 19.0
1-3 days 37.0 33.8 48.6 37.0 37.1 1-3 days 40.7 41.3 40.0 38.5 50.1
1  EMCDDA ‘Handbook for surveys on Drug Use among the General Population’ (Aug. 2002) defines frequency of drug use as:
 20 days or more = daily or almost daily; 10-19 days = several times a week; 4-9 days = at least once a week; 1-3 days = less than once a week.
Based on responses of those who had used cannabis in the last 30 days.
◆ Due to rounding, the weighted Ns for the gender or age categories do not always sum to the total weighted N.
All figures are based on weighted data. All figures are rounded to the nearest decimal place. All figures are based on valid responses.
Table 4: Ireland
Type of Cannabis Most Commonly Used (Current Users) (%) 
All 
adults
15-64
Male Female
Young 
adults
15-34
Older 
adults
35-64
Total Weighted N (valid responses) (128) (99)◆ (28)◆ (97) (31)
Hash 53.8 50.3 66.2 53.4 55.2
Grass 26.8 27.8 23.5 27.1 26.0
Resin 6.4 6.7 5.2 4.3 13.1
Weed 8.4 10.1 2.5 11.1 0.0
Herb 1.9 2.5 0.0 2.5 0.0
Skunk 1.2 1.6 0.0 1.6 0.0
Hash oil 0.8 1.1 0.0 0.0 3.4
Don’t know 0.6 0.0 2.6 0.0 2.4
Based on responses of those who had used cannabis in the last 30 days.
◆ Due to rounding, the weighted Ns for the gender or age categories do not always sum to the total weighted N.
All figures are based on weighted data. All figures are rounded to the nearest decimal place. All figures are based on valid responses.
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Table 5: Ireland
Cannabis Smokers (Grass/weed/herb/skunk): Grown in Ireland (Current Users) (%)
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Total Weighted N
(valid responses)
(49) (42) (7) (41) (8)
Yes 16.1 17.1 9.9 10.8 43.0
No 51.2 53.8 36.3 55.4 29.6
Don’t know 32.7 29.0 53.8 33.8 27.4
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
Table 6: Ireland
Method of Taking Cannabis (Current Users) (%) 
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Total Weighted N
(valid responses)
(128) (99)◆ (28)◆ (97) (31)
Joint 93.0 92.0 96.3 93.5 91.2
Pipe 3.7 4.7 0.0 3.4 4.5
Bong 2.5 3.2 0.0 2.0 4.3
Eat 0.8 0.0 3.7 1.1 0.0
Based on responses of those who had used cannabis in the last 30 days.
◆ Due to rounding, the weighted Ns for the gender or age categories do not always sum to the total weighted N.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
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Table 7: Ireland
How Cannabis was Obtained on Last Occasion (Recent Users) (%)
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Total Weighted N
(valid responses)
(311) (215) (96) (241) (70)
Given by family/friend 44.3 41.0 51.6 42.1 51.6
Shared amongst friends 28.3 26.0 33.4 31.9 15.8
Bought from a friend 14.6 18.5 5.8 13.8 17.2
Bought from contact not known personally 6.1 6.2 6.0 6.8 4.0
Given by stranger 1.4 2.0 0.0 0.7 3.8
Given by contact not known personally 2.7 2.7 2.6 2.4 3.5
Bought from a stranger 1.0 1.4 0.0 0.8 1.6
Don’t know 0.3 0.5 0.0 0.0 1.5
Refused to answer 1.4 1.8 0.6 1.5 1.0
Based on responses of those who had used cannabis in the last 12 months.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
Table 8: Ireland
Where Cannabis was Obtained on Last Occasion (Recent Users) (%)
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Total Weighted N (valid responses) (311) (215) (96) (241) (70)
House of friends 56.8 49.5 73.2 57.9 53.2
Disco/bar/club 7.9 9.9 3.3 8.0 7.3
Street/Park 12.2 13.1 10.3 10.8 17.1
Ordered by phone 5.2 6.3 2.6 5.1 5.2
House of a dealer 4.4 5.0 3.1 3.9 5.9
Other 0.0 0.0 0.0 0.0 0.0
School/College 2.8 3.5 1.3 3.2 1.5
Office/Workplace 1.7 2.4 0.0 1.6 1.9
Don’t know 0.8 0.8 0.7 1.0 0.0
Refused to answer 8.4 9.6 5.6 8.5 7.9
Based on responses of those who had used cannabis in the last 12 months.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
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Table 9: Ireland
Ease of Obtaining Cannabis in a 24-Hour Period (Recent Users) (%)
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Total Weighted N
(valid responses)
(311) (215) (96) (241) (70)
Very Easy 27.8 26.1 31.6 27.8 28.0
Fairly Easy 33.8 37.0 26.7 34.2 32.5
Neither easy or difficult 14.3 14.6 13.6 14.2 14.6
Fairly Difficult 15.9 16.2 15.0 17.4 10.4
Very Difficult 3.8 3.4 4.6 2.9 6.7
Don’t know 4.5 2.7 8.5 3.5 7.8
Based on responses of those who had used cannabis in the last 12 months.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
Table 10: Ireland
Regular Cannabis Users and Stopping Cannabis Use (%)
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Lifetime cannabis users who have ever used cannabis regularly
Total Weighted N (valid responses) (1087) (679) (408) (661) (426)
25.8 30.6 17.7 30.4 18.6
Regular cannabis users and stopping cannabis use 
Total Weighted N (valid responses) (280) (208) (72) (201) (79)
Regular user – Stopped taking 66.2 66.1 66.5 63.5 73.1
Regular user – Tried to stop but failed 9.6 8.4 13.2 9.3 10.4
Regular user – Never tried to stop 24.2 25.5 20.3 27.2 16.6
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
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Table 11: Ireland
Reasons for Stopping Cannabis Use (Regular Users Who Have Stopped) (%) 
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Total Weighted N (valid responses) (186) (137)◆ (48)◆ (128) (58)
Did not want to take any more 32.0 29.7 38.5 32.7 30.5
No longer part of social life 16.9 18.1 13.4 12.0 27.6
Did not enjoy after effects 6.5 5.7 9.0 6.7 6.1
Health concerns 18.9 20.8 13.3 20.1 16.2
Persuaded by friends/family 3.2 4.3 0.0 3.1 3.5
Cost/could no longer afford it 0.7 0.0 2.5 1.0 0.0
Impact on job/friends/family 7.0 8.8 1.8 10.1 0.0
Less available supply 1.3 1.0 2.1 0.0 4.0
Pregnancy 3.7 0.0 14.1 4.6 1.5
Pros did not outweigh cons 1.3 1.3 1.2 0.0 4.1
Rehab programme 1.7 1.8 1.5 1.2 2.7
Don’t know 7.1 8.6 2.6 8.6 3.7
◆ Due to rounding, the weighted Ns for the gender or age categories do not always sum to the total weighted N.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
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Table 12: Ireland
Attitudes Towards Cannabis Use (%)
GENERAL POPULATION THOSE WHO HAVE NEVER USED CANNABIS THOSE WHO HAVE EVER USED CANNABIS
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
People should be permitted to take cannabis for medical reasons 
Total Weighted N
(valid responses)
(4868) (2473) (2395) (2270)◆ (2599)◆ (3781) (1794) (1987) (1609)◆ (2173)◆ (1087) (679) (408) (661) (426)
Fully agree 44.1 46.3 41.9 42.2 45.8 39.3 40.3 38.4 35.9 41.8 61.1 62.3 58.9 57.6 66.3
Largely agree 27.0 27.2 26.8 26.0 27.9 27.4 28.1 26.7 25.5 28.8 25.6 24.6 27.4 27.2 23.2
Neither agree or disagree 8.3 8.2 8.5 9.9 7.0 9.2 9.3 9.1 11.6 7.4 5.2 5.2 5.3 5.6 4.7
Largely disagree 8.5 8.1 8.9 9.1 8.0 10.1 10.0 10.2 11.1 9.3 3.2 3.4 2.9 4.2 1.7
Fully disagree 10.0 8.5 11.5 10.8 9.2 11.7 10.2 13.0 13.5 10.3 4.1 3.9 4.4 4.4 3.7
Don’t know 2.0 1.7 2.3 2.0 2.0 2.4 2.2 2.6 2.4 2.4 0.8 0.5 1.1 1.0 0.3
People should be permitted to take cannabis for recreational reasons 
Total Weighted N
(valid responses)
(4868) (2473) (2395) (2270)◆ (2599)◆ (3781) (1794) (1987) (1609)◆ (2173)◆ (1087) (679) (408) (661) (426)
Fully agree 7.3 9.7 4.9 8.3 6.5 3.3 4.4 2.4 3.1 3.6 21.2 23.5 17.3 21.1 21.3
Largely agree 11.7 14.6 8.8 13.0 10.6 7.3 9.4 5.4 7.2 7.3 27.2 28.4 25.3 27.1 27.5
Neither agree or disagree 10.0 10.2 9.8 12.9 7.5 8.7 8.7 8.6 11.6 6.5 14.7 14.3 15.4 16.2 12.4
Largely disagree 21.8 21.4 22.1 21.8 21.7 22.3 22.6 22.1 22.1 22.4 19.9 18.4 22.4 20.9 18.3
Fully disagree 48.1 43.0 53.4 43.2 52.4 57.3 53.7 60.5 55.1 58.9 16.4 14.8 19.0 14.3 19.6
Don’t know 1.0 1.1 1.0 0.8 1.2 1.2 1.2 1.1 0.9 1.3 0.6 0.6 0.5 0.4 0.8
◆ Due to rounding, the weighted Ns for the gender or age categories do not always sum to the total weighted N.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
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Table 12: Ireland continued
Attitudes Towards Cannabis Use (%)
GENERAL POPULATION THOSE WHO HAVE NEVER USED CANNABIS THOSE WHO HAVE EVER USED CANNABIS
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
People smoking cannabis occasionally 
Total Weighted N
(valid responses)
(4868) (2473) (2395) (2270)◆ (2599)◆ (3781) (1794) (1987) (1609)◆ (2173)◆ (1087) (679) (408) (661) (426)
Do not disapprove 28.7 33.3 23.8 34.9 23.2 16.7 18.7 15.0 20.0 14.3 70.1 71.9 67.1 71.4 68.1
Disapprove 34.9 35.0 34.8 35.0 34.8 38.3 39.9 36.8 40.1 37.0 23.1 22.1 24.7 22.5 23.8
Strongly disapprove 35.6 30.7 40.6 29.4 40.9 44.0 40.3 47.3 39.2 47.5 6.3 5.4 7.8 5.7 7.2
Don’t know 0.9 0.9 0.8 0.6 1.1 1.0 1.0 0.9 0.7 1.1 0.6 0.6 0.5 0.4 0.8
Perceived risk related to smoking cannabis regularly 
Total Weighted N
(valid responses)
(4868) (2473) (2395) (2270)◆ (2599)◆ (3781) (1794) (1987) (1609)◆ (2173)◆ (1087) (679) (408) (661) (426)
No risk 1.8 2.3 1.3 2.6 1.1 0.7 0.6 0.7 1.2 0.3 5.8 6.6 4.5 6.1 5.3
Slight risk 11.7 14.2 9.1 15.9 8.0 7.5 9.4 5.8 10.8 5.1 26.1 26.8 25.0 28.4 22.5
Moderate risk 26.3 29.6 22.8 30.6 22.5 22.9 26.3 19.9 27.9 19.2 37.8 38.1 37.4 37.1 39.0
Great risk 59.5 53.3 66.0 50.4 67.6 68.1 62.8 72.8 59.4 74.5 29.9 28.1 32.9 28.3 32.4
Don’t know 0.7 0.7 0.7 0.5 0.8 0.8 0.8 0.8 0.7 0.9 0.4 0.3 0.2 0.0 0.7
◆ Due to rounding, the weighted Ns for the gender or age categories do not always sum to the total weighted N.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
29 National Advisory Committee on Drugs (NACD) & Public Health Information and Research Branch (PHIRB) December 2008
Drug Use in Ireland & Northern Ireland 2006/2007 Drug Prevalence Survey: Cannabis Results Bulletin 3
Table 13: Ireland
Cannabis Prevalence by Gender 
LIFETIME
PREVALENCE*
LAST YEAR
PREVALENCE*
LAST MONTH
PREVALENCE*
Cannabis Use Male Female Total Male Female Total Male Female Total
Total Weighted N
(valid responses)
(2513) (2454) (4967) (2513) (2454) (4967) (2513) (2454) (4967)
No 73.0 83.4 78.1 91.4 96.1 93.7 96.1 98.9 97.4
Yes 27.0 16.6 21.9 8.6 3.9 6.3 3.9 1.1 2.6
* p< 0.05
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
Table 14: Ireland
Cannabis Prevalence by Age Group
LIFETIME
PREVALENCE*
LAST YEAR
PREVALENCE*
LAST MONTH
PREVALENCE*
Cannabis Use 15-34 35-64 Total 15-34 35-64 Total 15-34 35-64 Total
Total Weighted N
(valid responses)
(2315) (2652) (4967) (2315) (2652) (4967) (2315) (2652) (4967)
No 71.4 83.9 78.1 89.6 97.4 93.7 95.8 98.8 97.4
Yes 28.6 16.1 21.9 10.4 2.6 6.3 4.2 1.2 2.6
* p< 0.05
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
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Table 15: Ireland
Cannabis Prevalence by Socio-Economic Group (SEG) (%)
A B C1 C2 D E Total
Total Weighted N 
(valid responses)
(232) (869) (1424) (1111) (800) (485) (4921)
Lifetime Prevalence by SEG*
No 73.7 78.9 73.5 79.4 81.9 81.6 78.0
Yes 26.3 21.1 26.5 20.6 18.1 18.4 22.0
Last Year Prevalence by SEG*
No 93.6 96.9 90.9 95.1 92.3 95.5 93.7
Yes 6.4 3.1 9.1 4.9 7.8 4.5 6.3
Last Month Prevalence by SEG*
No 98.7 99.5 96.1 97.9 96.4 97.3 97.4
Yes 1.3 0.5 3.9 2.1 3.6 2.7 2.6
* p< 0.05
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
Table 16: Ireland
Cannabis Prevalence by Work Status (%) 
In paid
work
Not in 
paid
work Student Other Total
Total Weighted N (valid responses) (3202) (1228) (525) (2) (4957)
Lifetime Prevalence*
No 75.5 84.3 80.2 100.0 78.2
Yes 24.5 15.7 19.8 0.0 21.8
Last Year Prevalence*
No 93.9 95.4 89.0 100.0 93.7
Yes 6.1 4.6 11.0 0.0 6.3
Last Month Prevalence
No 97.4 97.6 97.0 100.0 97.4
Yes 2.6 2.4 3.0 0.0 2.6
* p< 0.05
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
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Table 17: Ireland
Cannabis Prevalence by Housing Tenure (%) 
Owned 
in
part or 
full
Rented 
from
Private
Landlord
Rented
from
LA/HA Other Total
Total Weighted N
(valid responses) 
(3521) (931) (466) (48) (4966)
Lifetime Prevalence*
No 82.1 62.6 78.3 81.3 78.1
Yes 17.9 37.4 21.7 18.8 21.9
Last Year Prevalence*
No 96.1 85.4 93.4 89.6 93.7
Yes 3.9 14.6 6.6 10.4 6.3
Last Month Prevalence*
No 98.4 93.6 97.4 97.9 97.4
Yes 1.6 6.4 2.6 2.1 2.6
* p <0.05
LA/HA = Local Authority or Housing Association.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
Table 18: Ireland
Cannabis Prevalence by Age Education Ceased (%) 
15 years
& under 16-19
20 years
& over Total
Total Weighted N
(valid responses) 
(516) (1924) (1416) (3856)
Lifetime Prevalence*
No 84.5 82.0 71.3 78.4
Yes 15.5 18.0 28.7 21.6
Last Year Prevalence*
No 96.9 94.9 93.5 94.7
Yes 3.1 5.1 6.5 5.3
Last Month Prevalence
No 98.3 97.9 97.2 97.7
Yes 1.7 2.1 2.8 2.3
* p <0.05
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
32 National Advisory Committee on Drugs (NACD) & Public Health Information and Research Branch (PHIRB) December 2008
Drug Use in Ireland & Northern Ireland 2006/2007 Drug Prevalence Survey: Cannabis Results Bulletin 3
Table 19: Ireland
Cannabis Prevalence by Highest Education Level Attained (%) 
Elementary
Lower
second 
level
Upper
second 
level
Third
Level Total
Total Weighted N
(valid responses) 
(325) (1472) (1196) (1967) (4960)
Lifetime Prevalence*
No 90.5 83.4 78.0 72.2 78.1
Yes 9.5 16.6 22.0 27.8 21.9
Last Year Prevalence*
No 96.6 94.0 92.0 94.2 93.8
Yes 3.4 6.0 8.0 5.8 6.2
Last Month Prevalence
No 97.5 97.5 97.2 97.6 97.5
Yes 2.5 2.5 2.8 2.4 2.5
* p <0.05
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
Table 20: Ireland
Personally Know People Who Take Cannabis (%)
2002/3
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Total Weighted N
(valid responses)
(4870) (2442) (2428) (2316) (2554)
Yes 35.2 41.2 29.2 48.7 23.0
No 64.8 58.8 70.8 51.3 77.0
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
Table 21: Ireland
Personally Know People Who Take Cannabis (%)
2006/7
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Total Weighted N
(valid responses)
(4868) (2473) (2395) (2270)◆ (2599)◆
Yes 43.2 48.2 38.0 58.5 29.8
No 56.8 51.8 62.0 41.5 70.2
◆ Due to rounding, the weighted Ns for the gender or age categories do not always sum to the total weighted N.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
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Table 22: Ireland
Cannabis Prevalence by Regional Drugs Task Force (RDTF) Area (%) Cannabis Prevalence by Regional Drugs Task Force (RDTF) Area (%)
2006/7
All 
adults
15-64 Male Female
Young 
adults
15-34
Older 
adults
35-64
2002/3
All 
adults
15-64 Male Female
Young 
adults
15-34
Older 
adults
35-64
Lifetime Prevalence (%) Lifetime Prevalence (%)
East Coast RDTF 35.9* 42.9 29.5* 38.1 33.7* East Coast RDTF 24.5 32.3 16.4 33.4 17.4
Midlands RDTF 17.0 19.7 14.1 23.6 11.6 Midlands RDTF 10.7 13.3 7.9 14.6 7.4
Mid-Western RDTF 17.0 20.6 13.3 24.6 10.8 Mid-Western RDTF 10.9 13.7 8.1 16.5 6.1
North  Eastern  RDTF 19.5 25.2 13.4 25.0 14.9* North  Eastern  RDTF 17.8 24.2 11.0 30.4 6.7
North Western RDTF 12.8 16.8 8.7 18.9 8.2 North Western RDTF 9.3 11.9 6.6 10.7 8.2
Northern RDTF 28.8 37.0 20.7 40.3 18.4 Northern RDTF 26.9 35.2 19.1 34.1 19.9
South Eastern  RDTF 23.3 29.7 16.6 32.3 16.3* South Eastern  RDTF 16.8 22.0 11.4 25.4 9.8
South Western RDTF 24.0 29.6 18.2 28.1 19.5 South Western RDTF 23.2 30.2 16.5 28.3 16.5
Southern RDTF 15.0 17.9 12.0 20.1 10.8 Southern RDTF 11.6 13.6 9.5 17.1 6.9
Western RDTF 21.0* 26.1 15.8* 29.1* 14.5 Western RDTF 12.0 15.8 8.1 14.6 9.9
Last Year Prevalence (%) Last Year Prevalence (%)
East Coast RDTF 11.3* 13.8 9.0* 16.2 6.5* East Coast RDTF 6.1 9.6 2.5 11.4 1.9
Midlands RDTF 4.1 5.4 2.7 8.5 0.5 Midlands RDTF 2.8 3.6 1.9 5.1 0.8
Mid-Western RDTF 4.7 6.6 2.8 9.2 1.0 Mid-Western RDTF 3.0 3.9 2.0 5.5 0.8
North  Eastern  RDTF 4.6 6.4 2.6 7.8 1.9 North  Eastern  RDTF 5.2 7.8 2.4 10.6 0.4
North Western RDTF  2.9 3.9 2.0 6.8 0.0 North Western RDTF  2.2 3.4 0.9 3.9 0.8
Northern RDTF 11.9 17.6 6.3 18.9 5.5 Northern RDTF 7.7 12.2 3.4 12.6 2.9
South Eastern  RDTF 5.1 7.4 2.6 9.8 1.4 South Eastern  RDTF 5.8 7.9 3.6 11.2 1.3
South Western RDTF 6.7 8.9 4.4 8.8 4.4 South Western RDTF 7.3 10.6 4.2 10.0 3.8
Southern RDTF 4.6 6.9 2.1 8.6 1.3 Southern RDTF 4.4 4.8 4.0 7.9 1.4
Western RDTF 4.3 5.0 3.5 7.1* 2.0 Western RDTF 2.0 2.8 1.2 1.5 2.4
Last Month Prevalence (%) Last Month Prevalence (%)
East Coast RDTF 4.2 5.5 3.0 5.5 2.9 East Coast RDTF 3.8 5.4 2.2 7.5 1.0
Midlands RDTF 1.1 1.4 0.7 2.4 0.0 Midlands RDTF 1.0 2.0 0.0 1.3 0.8
Mid-Western RDTF 1.4 2.8 0.0 2.7 0.4 Mid-Western RDTF 1.6 1.9 1.4 2.6 0.8
North  Eastern  RDTF 0.8 1.3 0.3 1.5 0.3 North  Eastern  RDTF 1.9 2.9 0.9 3.6 0.4
North Western RDTF  0.3 0.0 0.6 0.7 0.0 North Western RDTF  0.2 0.0 0.5 0.0 0.4
Northern RDTF 7.9 12.5 3.3 13.0 3.2 Northern RDTF 4.5 6.9 2.3 7.5 1.7
South Eastern  RDTF 2.8 4.3 1.2 5.0 1.0 South Eastern  RDTF 2.1 2.5 1.7 4.7 0.0
South Western RDTF 1.8 2.5 1.0 1.9 1.6 South Western RDTF 3.9 6.1 1.8 5.6 1.7
Southern RDTF 2.0 3.7 0.2 3.5 0.7 Southern RDTF 2.1 1.9 2.3 4.1 0.4
Western RDTF 1.6 2.5 0.6 3.2 0.3 Western RDTF 1.3 1.4 1.2 0.6 1.9
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
*Indicates a significant change from 2002/3 to 2006/7
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Table 23: Northern Ireland
Cannabis Prevalence Rates (%) Cannabis Prevalence Rates (%)
2006/7
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
2002/3
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Total Weighted N (valid responses) (2000) (992)♦ (1009)♦ (843)Ü (1150)Ü Total Weighted N (valid responses) (3516) (1739) (1777) (1550) (1966)
Lifetime Prevalence (%) 24.7* 30.1* 19.3* 35.0* 17.3* Lifetime Prevalence (%) 16.8 23.3 10.5 25.1 10.3
Last Year Prevalence (Recent use) (%) 7.2* 10.3 4.1* 12.4 3.3* Last Year Prevalence (Recent use) (%) 5.4 8.7 2.2 9.8 2.0
Last Month Prevalence (Current use) (%) 2.6 3.7 1.6 3.7 1.8 Last Month Prevalence (Current use) (%) 2.9 5.1 0.8 5.4 1.0
◆	Due to rounding, the weighted Ns for the gender or age categories do not sum to the total weighted N.
Ü	Eight respondents confirmed they were eligible to participate in the survey but did not state their exact age.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
*Indicates a significant change from 2002/3 to 2006/7
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Table 24: Northern Ireland
 Age of First Use and First Regular Use of Cannabis
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Age first use cannabis (all users) 
Total Weighted N (valid responses) (493) (298) (195) (295)◆ (199)◆
Mean age of first use 20 20 21 18 24
Median of age of first use1 18 18 19 17 20
Age first use cannabis (regular users)
Total Weighted N (valid responses) (120) (87) (33) (83)◆ (38)◆
Mean age of first use 18 18 17 17 20
Median of age of first use1 16 16 16 16 19
Age first regular use cannabis (regular users)
Total Weighted N (valid responses) (120) (87) (33) (83)◆ (38)◆
Mean age of first use 20 20 20 18 23
Median of age of first use1 18 18 18 17 21
Average number of years between first use and first regular use of cannabis (regular users)2
Total Weighted N (valid responses) (120) (87) (33) (83)◆ (38)◆
Average number of years 2 2 2 1 3
1 Median is used as a measure of central tendency to avoid extreme values skewing results.
2 Lag was calculated by measuring the time in years between when a respondent reported first using cannabis and first using cannabis regularly.
◆ Due to rounding, the weighted Ns for the age categories do not sum to the total weighted N.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
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Table 25: Northern Ireland
Frequency of Cannabis Use1 (Current Users) (%) Frequency of Cannabis Use1 (Current Users) (%) 
2006/7
All 
adults
15-64 Male Female
Young 
adults
15-34
Older 
adults
35-64
2002/3
All 
adults
15-64 Male Female
Young 
adults
15-34
Older 
adults
35-64
Total Weighted N (valid responses) (53) (36)♦ (16)♦ (31)♦ (21)♦ Total Weighted N (valid responses) (103) (89) (14) (84) (19)
20 days or more 16.4 23.6 0.0 12.1 22.8 20 days or more 30.5 32.8 15.7 29.8 33.6
10-19 days 18.9 19.9 16.4 14.4 25.5 10-19 days 20.3 20.0 22.6 21.1 17.0
4-9 days 27.1 25.0 32.0 30.4 22.3 4-9 days 20.9 20.5 23.8 23.1 11.5
1-3 days 37.6 31.5 51.5 43.1 29.4 1-3 days 28.2 26.7 37.9 26.0 38.0
1 EMCDDA ‘Handbook for surveys on Drug Use among the General Population’ (Aug. 2002) defines frequency of drug use as:
 20 days or more = daily or almost daily; 10-19 days = several times a week; 4-9 days = at least once a week; 1-3 days = less than once a week.
Based on reponses of those who had used cannabis in the last 30 days.
◆	Due to rounding, the weighted Ns for the gender or age categories do not sum to the total weighted N.
All figures are based on weighted data. All figures are rounded to the nearest decimal place. All figures are based on valid responses.
Table 26: Northern Ireland
Type of Cannabis Most Commonly Used (Current Users) (%) 
All 
adults
15-64 Male Female
Young 
adults
15-34
Older 
adults
35-64
Total Weighted N (valid responses) (53) (36)◆ (16)◆ (31)◆ (21)◆
Hash 9.6 11.9 4.3 2.3 20.4
Grass 43.5 33.1 67.1 53.6 28.5
Resin 33.3 44.1 8.8 28.3 40.6
Weed 9.0 11.0 4.5 10.3 7.0
Herb 0.0 0.0 0.0 0.0 0.0
Skunk 1.5 0.0 4.8 2.4 0.0
Hash oil 0.0 0.0 0.0 0.0 0.0
Other 1.8 0.0 5.8 3.0 0.0
Don’t know 1.4 0.0 4.7 0.0 3.6
Based on responses of those who had used cannabis in the last 30 days.
◆ Due to rounding, the weighted Ns for the gender or age categories do not sum to the total weighted N.
All figures are based on weighted data. All figures are rounded to the nearest decimal place. All figures are based on valid responses.
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Table 27: Northern Ireland
Cannabis Smokers (Grass/weed/herb/skunk): Grown in Northern Ireland (Current Users) (%)
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Total Weighted N
(valid responses)
(28) (16) (12) (21)◆ (8)◆
Yes 31.1 40.7 18.4 25.3 47.1
No 30.8 28.1 34.5 26.1 44.1
Don’t know 38.1 31.2 47.1 48.6 8.8
◆ Due to rounding, the weighted Ns for the age categories do not sum to the total weighted N.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
Table 28: Northern Ireland
Method of Taking Cannabis (Current Users) (%) 
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Total Weighted N
(valid responses)
(53) (36)◆ (16)◆ (31)◆ (21)◆
Joint 85.2 92.0 69.8 77.7 96.4
Pipe 5.9 4.5 9.0 9.9 0.0
Bong 7.5 3.5 16.4 12.5 0.0
Eat 1.4 0.0 4.7 0.0 3.6
Based on responses of those who had used cannabis in the last 30 days.
◆ Due to rounding, the weighted Ns for the gender or age categories do not sum to the total weighted N.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
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Table 29: Northern Ireland
How Cannabis was Obtained on Last Occasion (Recent Users) (%)
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Total Weighted N
(valid responses)
(143) (102) (41) (105) (38)
Given by family/friend 30.5 27.9 36.7 33.2 23.1
Shared amongst friends 35.3 34.8 36.5 39.0 25.1
Bought from a friend 18.0 23.3 4.9 14.7 26.9
Bought from contact not known personally 5.3 2.1 13.1 5.0 6.0
Given by stranger 1.0 0.7 1.7 0.7 1.8
Given by contact not known personally 6.2 6.6 5.2 6.4 5.6
Bought from a stranger 3.3 4.6 0.0 1.0 9.6
Other 0.5 0.0 1.8 0.0 2.0
Based on responses of those who had used cannabis in the last 12 months.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
Table 30: Northern Ireland
Where Cannabis was Obtained on Last Occasion (Recent Users) (%)
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Total Weighted N (valid responses) (143) (102) (41) (105) (38)
House of friends 55.9 53.9 60.7 58.5 48.6
Disco/bar/club 16.7 19.3 10.3 12.5 28.0
Street/Park 8.7 7.0 12.8 10.9 2.5
Ordered by phone 5.5 6.3 3.5 4.7 7.7
House of a dealer 5.8 4.6 8.7 5.6 6.2
School/College 0.0 0.0 0.0 0.0 0.0
Office/Workplace 0.5 0.7 0.0 0.7 0.0
Other 7.0 8.1 4.1 7.0 6.9
Based on responses of those who had used cannabis in the last 12 months.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
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Table 31: Northern Ireland
Ease of Obtaining Cannabis in a 24-Hour Period (Recent Users) (%)
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Total Weighted N
(valid responses)
(143) (102) (41) (105) (38)
Very Easy 36.7 36.2 37.9 37.2 35.3
Fairly Easy 38.5 40.7 33.0 39.7 35.0
Neither easy or difficult 5.4 2.3 13.1 5.5 5.3
Fairly Difficult 7.5 9.0 3.9 8.0 6.2
Very Difficult 7.2 6.6 8.6 7.1 7.3
Don’t know 4.7 5.2 3.6 2.4 11.0
Based on responses of those who had used cannabis in the last 12 months.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
Table 32: Northern Ireland
Regular Cannabis Users and Stopping Cannabis Use (%)
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Lifetime cannabis users who have ever used cannabis regularly
Total Weighted N (valid responses) (493) (298) (195) (295)◆ (199)◆
24.4 29.3 16.8 28.1 18.9
Regular cannabis users and stopping cannabis use 
Total Weighted N (valid responses) (120) (87) (33) (83)◆ (38)◆
Regular user – Stopped taking 74.3 73.9 75.5 77.2 68.0
Regular user – Tried to stop but failed 12.6 11.4 15.9 10.2 17.9
Regular user – Never tried to stop 13.1 14.8 8.7 12.6 14.1
◆ Due to rounding, the weighted Ns for the age categories do not sum to the total weighted N.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
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Table 33: Northern Ireland
Reasons for Stopping Cannabis Use (Regular Users Who Have Stopped) (%) 
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Total Weighted N (valid responses) (89) (65)◆ (25)◆ (64)◆ (26)◆
Did not want to take any more 36.0 34.2 40.6 38.7 29.2
No longer part of social life 24.5 23.7 26.6 18.5 39.4
Did not enjoy after effects 7.0 6.2 9.3 8.4 3.5
Health concerns 9.1 10.6 5.1 9.2 8.8
Persuaded by friends/family 1.6 1.1 2.9 1.1 2.9
Cost/could no longer afford it 9.1 11.1 3.8 10.4 5.8
Impact on job/friends/family 5.1 5.9 2.9 6.0 2.9
Less available supply 0.0 0.0 0.0 0.0 0.0
Pregnancy 2.4 0.0 8.8 3.4 0.0
Pros did not outweigh cons 3.3 4.6 0.0 1.6 7.6
Rehab programme 1.1 1.6 0.0 1.6 0.0
Other 0.8 1.1 0.0 1.1 0.0
◆ Due to rounding, the weighted Ns for the gender or age categories do not sum to the total weighted N.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
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Table 34: Northern Ireland
Attitudes Towards Cannabis Use (%)
GENERAL POPULATION THOSE WHO HAVE NEVER USED CANNABIS THOSE WHO HAVE EVER USED CANNABIS
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
People should be permitted to take cannabis for medical reasons 
Total Weighted N
(valid responses)
(1961) (974) (987) (831)Ü (1125)Ü (1468) (676) (792) (536)Ü (926)Ü (493) (298) (195) (295)◆ (199)◆
Fully agree 39.0 41.6 36.5 36.8 40.9 33.4 33.0 33.7 28.3 36.5 55.9 61.1 47.9 52.2 61.4
Largely agree 33.8 34.9 32.6 35.0 32.9 34.3 38.1 31.0 34.9 33.9 32.3 27.9 39.1 35.0 28.3
Neither agree or disagree 11.6 9.7 13.4 12.6 10.6 13.2 11.3 14.9 15.8 11.6 6.6 6.1 7.2 6.9 6.1
Largely disagree 8.1 6.9 9.3 9.3 7.3 9.8 8.7 10.8 12.3 8.4 3.2 2.9 3.5 3.9 2.1
Fully disagree 6.8 6.3 7.3 5.9 7.3 8.4 8.2 8.6 8.1 8.4 1.9 1.9 2.0 1.8 2.2
Don’t know 0.7 0.5 0.9 0.4 1.0 0.9 0.8 1.1 0.5 1.2 0.1 0.0 0.3 0.2 0.0
People should be permitted to take cannabis for recreational reasons 
Total Weighted N
(valid responses)
(1961) (974) (987) (831)Ü (1125)Ü (1468) (676) (792) (536)Ü (926)Ü (493) (298) (195) (295)◆ (199)◆
Fully agree 6.0 8.4 3.7 7.5 5.0 2.3 2.5 2.1 2.6 2.2 17.1 21.6 10.1 16.3 18.2
Largely agree 12.0 14.0 10.0 15.2 9.6 7.2 8.0 6.6 10.3 5.4 26.1 27.6 24.0 24.1 29.1
Neither agree or disagree 14.3 15.5 13.1 16.4 12.9 13.3 15.6 11.3 15.4 12.2 17.4 15.3 20.5 18.1 16.2
Largely disagree 25.2 24.0 26.5 28.6 22.8 25.5 24.4 26.4 29.2 23.3 24.6 23.2 26.7 27.5 20.2
Fully disagree 42.0 37.6 46.4 32.3 49.1 51.2 48.7 53.3 42.4 56.2 14.9 12.3 18.7 14.0 16.2
Don’t know 0.4 0.5 0.3 0.1 0.6 0.5 0.7 0.3 0.1 0.7 0.0 0.0 0.0 0.0 0.0
Ü Six respondents who were routed to this question confirmed they were eligible to participate in the survey but did not state their exact age.
◆ Due to rounding, the weighted Ns for the age categories do not sum to the total weighted N.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
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Table 34: Northern Ireland continued
Attitudes Towards Cannabis Use (%)
GENERAL POPULATION THOSE WHO HAVE NEVER USED CANNABIS THOSE WHO HAVE EVER USED CANNABIS
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
People smoking cannabis occasionally 
Total Weighted N
(valid responses)
(1961) (974) (987) (831)Ü (1124)Ü (1468) (675)◆ (792)◆ (536)Ü (926)Ü (493) (298) (195) (295)◆ (199)◆
Do not disapprove 30.9 35.4 26.4 39.9 24.4 18.6 19.3 18.1 24.4 15.4 67.3 71.9 60.3 67.9 66.3
Disapprove 38.7 37.1 40.2 38.6 38.7 43.3 43.6 43.1 47.1 41.1 24.8 22.4 28.5 23.3 27.1
Strongly disapprove 30.0 26.9 33.1 21.5 36.2 37.6 36.5 38.5 28.5 42.7 7.4 5.0 11.2 8.7 5.6
Don’t know 0.4 0.6 0.3 0.0 0.8 0.5 0.6 0.3 0.0 0.7 0.4 0.7 0.0 0.0 1.0
Perceived risk related to smoking cannabis regularly 
Total Weighted N
(valid responses)
(1961) (974) (987) (831)Ü (1124)Ü (1468) (675)◆ (792)◆ (536)Ü (926)Ü (493) (298) (195) (295)◆ (199)◆
No risk 1.4 2.1 0.8 2.8 0.4 0.7 1.1 0.5 1.6 0.3 3.6 4.4 2.3 5.1 1.3
Slight risk 9.1 11.0 7.3 11.7 7.3 5.5 6.5 4.7 6.5 5.0 19.9 21.1 17.9 21.1 18.0
Moderate risk 26.2 29.7 22.8 32.2 21.9 21.7 24.7 19.2 28.2 18.1 39.6 41.1 37.3 39.6 39.6
Great risk 62.9 57.0 68.8 53.1 70.0 71.6 67.4 75.2 63.4 76.2 37.0 33.4 42.5 34.3 41.1
Don’t know 0.3 0.2 0.4 0.2 0.4 0.4 0.3 0.5 0.3 0.5 0.0 0.0 0.0 0.0 0.0
Ü Six respondents who were routed to this question confirmed they were eligible to participate in the survey but did not state their exact age.
◆ Due to rounding, the weighted Ns for the gender or age categories do not always sum to the total weighted N.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
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Table 35: Northern Ireland
Cannabis Prevalence by Gender 
LIFETIME
PREVALENCE*
LAST YEAR
PREVALENCE*
LAST MONTH
PREVALENCE*
Cannabis Use Male Female Total Male Female Total Male Female Total
Total Weighted N
(valid responses)
(992)◆ (1009)◆ (2000) (991)◆ (1009)◆ (1999) (991)◆ (1009)◆ (1999)
No 69.9 80.7 75.3 89.7 95.9 92.8 96.3 98.4 97.4
Yes 30.1 19.3 24.7 10.3 4.1 7.2 3.7 1.6 2.6
* p< 0.05
◆ Due to rounding, the weighted Ns for the gender categories do not sum to the total weighted N.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
Table 36: Northern Ireland
Cannabis Prevalence by Age Group
LIFETIME
PREVALENCE*
LAST YEAR
PREVALENCE*
LAST MONTH
PREVALENCE*
Cannabis Use 15-34 35-64 Total 15-34 35-64 Total 15-34 35-64 Total
Total Weighted N
(valid responses)
(843)◆ (1150)◆ (1992)Ü (842)◆ (1150)◆ (1991)Ü (842)◆ (1150)◆ (1991)Ü
No 65.0 82.7 75.3 87.6 96.7 92.8 96.3 98.2 97.4
Yes 35.0 17.3 24.7 12.4 3.3 7.2 3.7 1.8 2.6
* p< 0.05
Ü Eight respondents confirmed they were eligible to participate in the survey, but did not state their exact age.
◆ Due to rounding, the weighted Ns for the age categories do not sum to the total weighted N.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
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Table 37: Northern Ireland
Cannabis Prevalence by National Statistics Socio-Economic Classification (NSSEC) (%)
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Total Weighted N  
(valid responses)
(534) (211) (202) (130) (637) (106) (172) (1992)
Lifetime Prevalence*
No 74.9 78.7 78.5 84.1 70.8 72.0 81.3 75.3
Yes 25.1 21.3 21.5 15.9 29.2 28.0 18.7 24.7
Last Year Prevalence*
No 95.6 98.0 91.7 94.8 89.5 93.9 89.3 92.8
Yes 4.4 2.0 8.3 5.2 10.5 6.1 10.7 7.2
Last Month Prevalence*
No 98.4 100.0 95.4 98.7 95.4 97.1 99.5 97.4
Yes 1.6 0.0 4.6 1.3 4.6 2.9 0.5 2.6
* p< 0.05
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
Table 38: Northern Ireland
Cannabis Prevalence by Work Status (%) 
In paid
work
Not in 
paid
work Other Total
Total Weighted N (valid responses) (1243) (607) (150) (2000)
Lifetime Prevalence*
No 73.2 77.6 83.6 75.3
Yes 26.8 22.4 16.4 24.7
Last Year Prevalence
No 93.2 92.9 89.8 92.8
Yes 6.8 7.1 10.2 7.2
Last Month Prevalence
No 97.6 96.3 99.4 97.4
Yes 2.4 3.7 0.6 2.6
*  p< 0.05
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
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Table 39: Northern Ireland
Cannabis Prevalence by Housing Tenure (%) 
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Total Weighted N
(valid responses) 
(527) (908) (5) (244) (38) (256) (16) (1996)◆
Lifetime Prevalence*
No 88.0 74.0 76.4 69.9 60.4 62.7 49.0 75.3
Yes 12.0 26.0 23.6 30.1 39.6 37.3 51.0 24.7
Last Year Prevalence*
No 97.6 94.1 76.4 89.8 87.5 83.8 75.2 92.8
Yes 2.4 5.9 23.6 10.2 12.5 16.2 24.8 7.2
Last Month Prevalence*
No 99.7 98.3 76.4 95.2 93.9 93.8 75.2 97.4
Yes 0.3 1.7 23.6 4.8 6.1 6.2 24.8 2.6
* p <0.05
◆ Due to rounding, the weighted Ns for the housing tenure categories do not sum to the total weighted N.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
Table 40: Northern Ireland
Cannabis Prevalence by Highest Qualification Level Attained (%) 
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Total Weighted N
(valid responses) 
(310) (237) (355) (434) (159) (504) (2000)◆
Lifetime Prevalence*
No 72.7 71.3 71.4 72.9 74.0 84.2 75.3
Yes 27.3 28.7 28.6 27.1 26.0 15.8 24.7
Last Year Prevalence*
No 96.6 94.1 91.4 89.0 92.2 94.5 92.8
Yes 3.4 5.9 8.6 11.0 7.8 5.5 7.2
Last Month Prevalence*
No 99.8 99.1 96.2 95.4 96.9 97.8 97.4
Yes 0.2 0.9 3.8 4.6 3.1 2.2 2.6
*  p <0.05
◆ Due to rounding, the weighted Ns for the qualification categories do not sum to the total weighted N.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
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Table 41: Northern Ireland
Personally Know People Who Take Cannabis (%)
2002/3
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Total Weighted N
(valid responses)
(3483) (1725) (1758) (1541) (1942)
Yes 33.9 42.2 25.8 49.6 21.5
No 66.1 57.8 74.2 50.4 78.5
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
Table 42: Northern Ireland
Personally Know People Who Take Cannabis (%)
2006/7
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Total Weighted N
(valid responses)
(1962) (974) (988) (831)Ü (1125)Ü
Yes 45.7 50.9 40.7 62.0 33.8
No 54.3 49.1 59.3 38.0 66.2
Ü Six respondents who were routed to this question confirmed they were eligible to participate in the survey but did not 
state their exact age.
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
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Table 43: Northern Ireland
Cannabis Prevalence by Health and Social Services Board (HSSB) Area (%) Cannabis Prevalence by Health and Social Services Board (HSSB) Area (%)
2006/7
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
2002/3
All
adults
15-64 Male Female
Young
adults
15-34
Older
adults
35-64
Lifetime Prevalence (%) Lifetime Prevalence (%)
Eastern HSSB 32.2* 40.3* 24.5* 46.2* 22.1* Eastern HSSB 18.9 26.2 12.0 27.4 12.3
Northern HSSB 22.2* 26.2 18.3* 33.8* 14.4* Northern HSSB 14.4 19.5 9.3 22.8 8.1
Southern HSSB 18.7 23.1 14.3 25.6 13.6 Southern HSSB 16.3 23.0 9.5 23.9 10.2
Western HSSB 18.1 21.5 14.6 22.6 14.8* Western HSSB 16.3 22.5 9.9 24.5      9.2
Last Year Prevalence (%) Last Year Prevalence (%)
Eastern HSSB 8.7 12.0 5.5 14.4 4.5 Eastern HSSB 6.0 9.3 2.9 10.8 2.2
Northern HSSB 6.5 9.7 3.4 11.8 3.0 Northern HSSB 5.4 9.1 1.7 9.8 2.1
Southern HSSB 7.1 10.2 4.0* 13.0 2.7 Southern HSSB 4.3 7.9 0.7 7.9 1.5
Western HSSB 4.7 7.5 1.8 8.3 1.9 Western HSSB 5.3 7.4 3.2 9.4 1.8
Last Month Prevalence (%) Last Month Prevalence (%)
Eastern HSSB 3.5 5.1 2.1 3.6 3.5* Eastern HSSB 3.4 5.9 1.0 6.6 0.9
Northern HSSB 1.6 2.0* 1.1 2.5 0.9 Northern HSSB 3.5 6.2 0.8 6.1 1.5
Southern HSSB 3.5* 5.2 1.8* 7.8* 0.3 Southern HSSB 1.5 3.1 0.0 2.9 0.5
Western HSSB 1.2 1.5 0.9 1.2 1.2 Western HSSB 1.3 1.5 0.3 2.0 0.1
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
*Indicates a significant change from 2002/3 to 2006/7
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